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Abstract 
 
JONATHAN SEAVER EDWARDS: Structure and Function of the NES Relaxase and C-terminal 
Domains Required for Vancomycin Resistance Transfer	  
(Under the direction of Matthew R. Redinbo) 
 
 Antibiotic resistance has become a large burden in the healthcare setting due to 
increasing rates of mortality and increased healthcare costs due to extended treatment. 
Staphylococcus aureus is one of the most prevalent healthcare associated infections (HAI) and 
has recently become resistant to vancomycin (VRSA). This is a serious problem as vancomycin is 
one of the last lines of defense against resistant gram-positive bacteria. Given this new resistance 
combined with the fact that novel antibiotic approval has steadily been decreasing we sought to 
better understand the process of conjugative plasmid transfer (CPT) for the vancomycin 
resistance plasmid in S. aureus, pLW1043.  
 We focused on a key enzyme involved in CPT, the relaxase. The relaxase on pLW1043 
has been identified through sequence analysis and is termed the nicking enzyme of S. aureus 
(NES). The relaxase initiates and terminates CPT. When CPT has been initiated the relaxase will 
bind to and nic the DNA at a specific location on the plasmid termed the oriT.  
 We hypothesized that inhibition of the relaxase would halt the spread of antibiotic 
resistance and could result in a novel class of antibiotics. To investigate this hypothesis, we set 
out to determine the structure of NES, understand its biological function, and investigate its 
interaction with the oriT DNA. Little work has been conducted in gram-positive bacteria and by 
understanding this critical enzymes role in CPT we hoped to provide new insights to the scientific 
community.  
 In the following chapters we discuss the structure of the N-terminal relaxase domain in 
complex with DNA. Furthermore, we will use this structural information combined with 
	  iv	  
biochemical assays to identify how NES recognizes and site specifically cleaves the DNA at the 
proper location. We will then investigate the activity of NES with different metals and shed light 
on the elements required for proper cleavage and religation. Using this data, we then propose a 
novel strategy for the inhibition of NES and the development of novel antibiotics. Finally, we will 
analyze the structure of the C-terminal domain, which has no known function, and propose a role 
for its function in the DNA processing reaction.  
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Chapter 1 
 
Staphylococcus aureus Antibiotic Resistance and Conjugative DNA Transfer 
 
1.1 Staphylococcus aureus Effect on Healthcare and Antibiotic Resistance 
 Staphylococcus aureus (S. aureus) is a gram-positive, facultative anaerobic, coccal 
bacteria. It typically resides as part of the normal flora of the skin, especially around the nasal 
passages 1. Nosocomial infections, or healthcare acquired infections (HAIs), are one of the top 10 
causes of deaths per year in the United States and cost the healthcare system more than $20 
billion annually 2. S. aureus is one of the four most common HAIs. One of the major reasons 
these infections are so difficult to treat is due to the presence of antibiotic resistance. Shortly after 
the introduction of the first antibiotic, penicillin, it was observed that bacteria are able to gain 
resistance to these compounds 3. Furthermore, statistics from the Center for Disease Control 
(CDC) demonstrate that more people die from methicillin resistant S. aureus than AIDS 4. 
Because of these issues, the World Health Organization has declared antibiotic resistance a top 
priority for the health of the human population. Antibiotic resistance results in a large cost to our 
healthcare system by extending the average length of stay, making low cost drugs ineffective, and 
allowing secondary illnesses to progress faster 5. Antibiotics select for bacteria that are able to 
evade the effects of these compounds, and this selection has placed significant pressure on 
pharmaceutical companies to stop development of antibiotics because it is difficult to make a 
return on the investment. This lack of development results in an innovation gap for novel 
compounds 6 (Figure 1.1).  
 One of the major concerns for healthcare professionals is the acquisition of vancomycin 
resistance by bacteria. Vancomycin is a glycopeptide antibiotic (Figure 1.2) that is efficient at 
killing recalcitrant infections in gram-positive bacteria and is typically used as a
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 last resort due to drug administration and toxicity issues 7. It was discovered in 1953 in a soil 
sample from the jungles of Borneo.  The primary mechanism of action is to inhibit cell wall 
synthesis in gram-positive bacteria. It does this by binding to terminal D-alanyl-D-alanine 
moieties found on the N-acetylmuramic acid (NAM) and N-acetylglucosamine (NAG) peptides. 
This results in a large hydrophilic molecule being present in the forming cell wall that prevents 
the efficient crosslinking and elongation of polymers, and results in cell death.  
 S. aureus has shown the ability to rapidly develop resistance to numerous antibiotics. As 
previously mentioned, after penicillin was introduced in the 1940’s it was found that 60% of 
isolates contained a β-lactamase that contributed to penicillin resistance 8. Methicillin was 
introduced in 1961 as semisynthetic version of a β-lactam that would be able to evade the effects 
of penicillin resistance. However, methicillin-resistant S. aureus (MRSA) was soon identified. 
This resistance was possible because of the acquisition of the mecA gene that encodes for an 
alternate penicillin-binding protein transpeptidase (PBP2A) 9,10. Furthermore, other classes of 
antibiotics have been developed that had an effect on S. aureus but resistance soon emerged. 
These antibiotics include macrolides, lincosamides, aminoglycosides and quinolones, as well as 
newer antibiotics such as linezolid, daptomycin, and quinupristin-dalfopristin. As a result of this 
resistance, vancomycin, licensed in 1958, has become the drug of choice for difficult to treat S. 
aureus infections. Contrary to the other antibiotics it took nearly 40 years for any type of 
resistance to vancomycin to emerge. In 1997 the first reported case of a clinical isolate of S. 
aureus that had reduced susceptibility to vancomycin (MIC = 8 µg/mL) was identified and termed 
vancomycin-intermediate S. aureus (VISA) 11. This strain of S. aureus is able to evade the effects 
of vancomycin through producing more D-ala-D-ala targets, which vancomycin recognizes, in its 
peptidoglycan layer. By creating a thicker cell wall the bacteria are able to evade the effects of 
vancomycin before it is able to completely disrupt the cell wall resulting in cell death 12-14. In 
2002 a S. aureus isolate with a MIC for vancomycin of 1024 µg/mL was found in a dialysis 
patient in Michigan indicating high-level resistance 15. Upon sequencing the resistance plasmid 
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(pLW1043) in this isolate the vanA gene cluster was found 16. This strain of vancomycin-resistant 
S. aureus is now referred to as VRSA. 
 The vanA gene cluster allows for the resistance pathway to become inducible in VRSA. 
This is a great benefit to the bacteria because VISA isolates and other resistant bacteria often 
spend considerable resources evading the effects of antibiotics. By only supporting vancomycin 
resistance pathways when the drug is present, these bacteria are at significant advantage to other 
resistant bacteria. Upon sensing vancomycin the bacteria are able to initiate this alternate pathway 
for cell wall synthesis. Effectively, the bacteria eliminate the old D-ala-D-ala targets and replace 
them with D-ala-D-lac 17. This allows for the continual growth of the cell wall while in the 
presence of vancomycin (Figure 1.3).  
1.2 Conjugative Plasmid Transfer in Gram Positive Bacteria 
 Bacteria store their genetic material on either a chromosome or an extra-chromosomal 
element. The extra-chromosomal elements are often mobilizable and are able to move between 
bacterial hosts as well as into chromosomes. Extra-chromosomal elements include gene cassettes, 
transposons, bacteriophages, and single- or double-stranded plasmids 18-20. Bacteria are able to 
transfer their genetic material through two routes depending on the direction of transfer. Vertical 
gene transfer is the process through which bacteria will duplicate the genetic material and 
distribute a copy of both chromosomal and extra-chromosomal elements to each of the daughter 
cells. Horizontal gene transfer (HGT) is the process in which the extra-chromosomal elements are 
copied and distributed to a recipient bacterial cell. HGT is the primary pathway responsible for 
the dissemination of extra-chromosomal elements that contain antibiotic resistance genes 21. 
 HGT transfer of double-stranded DNA (dsDNA) plasmids between bacteria is referred to 
as conjugative plasmid transfer (CPT). dsDNA plasmids are classified into two major categories 
based on their ability for transfer: conjugative or mobilizable. Both types of plasmids contain the 
mobility (MOB) set of enzymes that allow for DNA replication. Conjugative plasmids contain the 
genes for the type 4 secretion system (T4SS) required to process and transfer the DNA from the 
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donor to recipient bacteria during CPT. Mobilizable plasmids can be transferred but do not posses 
all of the genes necessary for self transfer requiring another plasmid or chromosome with T4SS 
capabilities 19. 
 To date, more information is known about the process of HGT in gram-negative bacteria, 
and as such, that information is used as a model system for gram-positive bacteria. The major 
differences in the transfer mechanism are believed to be due to the difference in the formation of 
the cell walls and membranes between gram-negative and gram-positive bacteria. Gram-negative 
bacteria have a cytoplasmic membrane followed by a thin layer of peptidoglycan and an outer 
membrane. In contrast, gram-positive bacteria have a cytoplasmic membrane covered by a thick 
outer layer of peptidoglycan. The main differences in HGT between the species is believed to 
arise in the way these cells form cell-cell contact to initiate the transfer process 21.  
 When cells make tight cell-to-cell contact CPT can begin. During conjugation, two multi-
protein complexes form to process the DNA. The first complex, T4SS in gram-negative species, 
assembles to mediate DNA transfer from donor to recipient. The second complex, the relaxosome, 
forms in unison with the T4SS and prepares the DNA for transfer 21. Together these complexes 
allow the cell to transfer a plasmid via conjugation (Figure 1.4). The components of the 
relaxosome vary between species and plasmids but have similar functions. In order to have 
successful conjugation two factors are required of the plasmid. An origin of transfer (oriT) must 
be present to act as a cis regulator and a site where conjugation initiates and terminates termed nic. 
Also, there must be a gene encoding a site-specific relaxase that cleaves a phosphodiester bond of 
single stranded DNA at the nic site 22-24. These enzymes are present in all relaxosomes and 
provide a novel target for antibiotics. 
1.3 The Relaxase NES – Domain Organization and Mechanism 
 Relaxases are an integral part of the relaxosome and are responsible for carrying out the 
DNA cleavage and religation reactions. They are transferases that can cleave and religate ssDNA 
through transesterification in a site- and strand-specific manner. They contain an N-terminal 
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relaxase domain while the C-terminal domains can have helicase, primase, or other activities that 
depend on the host in which the relaxase resides 25. The relaxase present in the VRSA plasmid 
pLW1043 is named nicking enzyme of S. aureus (NES). Interestingly, in NES the C-terminal 
domain shows no relationship to these previously described functions based on sequence 
homology or secondary structure prediction. Relaxases are separated into two large families, Mob 
or Rep, based on the order of the elements contained in their conserved motifs 26. Motif I consists 
of one to four conserved catalytically active tyrosines. Motif II will have either a conserved 
aspartic acid or glutamic acid 27. Motif III contains two conserved histidine residues that are 
proposed to coordinate a divalent metal ion in the transesterifcation reaction 28. The typical 
histidine motif is HUHUUU where U represents a bulky hydrophobic amino acid. The one 
catalytically active tyrosine of NES is N-terminal to the HUH motif, thus classifying it as a Mob 
type relaxase. 
 Relaxases initiate and terminate conjugation through their single stranded nicking and 
ligation activity. They recognize and bind DNA at a specific site on the plasmid called the oriT. 
By recognizing specific bases present in the oriT, the relaxase can bind to the proper location on 
the plasmid. Once the relaxase has bound the oriT it will catalyze the cleavage of the scissile 
phosphodiester bond 29. The active site will position the DNA so that the tyrosine hydroxyl can 
act as a nucleophile to attack the scissile bond in the DNA backbone. After cleavage, the 5’ end 
of the DNA is covalently bound to the relaxase via a phosphodiester bond. Figure 1.5 depicts the 
proposed mechanism for NES. The HUH motif is shown coordinating a Ni2+ cation as was 
determined from ICP-MS (Table 3.3). A specific base, such as a water molecule, is most likely 
abstracting the hydrogen from the hydroxyl on the catalytic tyrosine because the structure did not 
reveal any amino acid side chains within the appropriate distance. Once the DNA is positioned by 
the divalent cation the tyrosine can attack the scissile phosphate at the nic site between Gua28 and 
Cyt29. The 3’ end of the cut DNA now has a hydroxyl and is released from the active site. The 
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DNA will then be transferred in a 5’ to 3’ direction into the recipient bacteria. The reaction is 
reversible with the 3’ hydroxyl acting as a nucleophile 29. 
 NES was first classified by Climo et. al in 1996 25. They were able to demonstrate that 
NES is required for the successful conjugative transfer of the plasmid pGO1. They were also able 
to locate the oriT on the plasmid and show that the relaxase cleaves where it would be predicted 
to based upon other sequence similarities of well characterized conjugative plasmids. The N-
terminal region of NES on plasmid plw1043 has a 26% sequence similarity with the MobA 
relaxase but no sequence similarity is present for the C-terminal domain.  The C-terminal could 
prove to be a dimer interface as suspected for TraI of the plasmid RP4 22 or act as a docking 
domain in the relaxosome. Once bound, the relaxase will catalyze the transesterifcation of the 
DNA at the nic site. This will allow the DNA to be unwound and transferred into the recipient 
cell. Many structures of gram-negative relaxases have been solved with inhibitors or in complex 
with DNA. However, there is only one structure of a Mob relaxase containing a single tyrosine in 
the active site. Furthermore, it was in apo form and from a gram-negative organism 30. The goal 
of this research is to learn more about the biochemical function of NES as well as determine the 
crystal structure of the enzyme for use in structural analysis through mutations and to develop 
novel antibiotics that inhibit its function.  
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A. Increase in Drug Resistance Among Pathogens  B. Decreased Number of New Drugs in the Market 
Source: Clinical Micro Infect 2004; 10 (Suppl. 4): 1-9 Source: Nat Biotech 2006 24: 1521 
Figure 1.1 Increases in Antibiotic Resistance Compared to New Drugs in the Market 
Figure 1.2 Structure of Vancomycin 
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Source: Hughes, D. (2003) Exploiting genomics, genetics and chemistry to combat antibiotic  
resistance, Nature reviews 4, 432-441. 
	  
	  
Figure 1.3  VRSA and VRE Vancomycin Resistance Mechanism 
 
A two-component regulatory system VanR–VanS regulates vancomycin resistance in 
vancomycin-resistant enterococci (VRE) and vancomycin-resistant Staphylococcus aureus 
(VRSA) strains. VanS is a membrane-associated sensor (of vancomycin) that controls the 
level of phosphorylation of VanR. VanR is a transcriptional activator of the operon encoding 
VanH, VanA and VanX. VanH is a dehydrogenase that reduces pyruvate to D-Lac, whereas 
VanA is a ligase that catalyses the formation of an ester bond between D-Ala and D-Lac. 
Vancomycin does not bind to D-Ala-D-Lac, which leads to vancomycin resistance. VanX is a 
dipeptidase that hydrolyses the normal peptidoglycan component D-Ala-D-Ala, which 
prevents it from causing vancomycin sensitivity. VanY is a D,D-carboxypeptidase that 
hydrolyses the terminal D-Ala residue of late peptidoglycan precursors that are produced if 
elimination of D-Ala-D-Ala by VanX is not complete. So, D-Ala-D-Lac replaces the normal 
dipeptide D-Ala-D-Ala in peptidoglycan synthesis resulting in vancomycin resistance150. 
VanZ confers resistance to teicoplanin by an unknown mechanism. 
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Figure 1.4  Conjugative Plasmid Transfer 
 
Schematic representation of CPT in bacteria. A donor cell is shown with chromosomal DNA 
and a resistance plasmid that is capable of transfer. Upon the formation of the Type 4 
Secretion System (T4SS) the relaxosome, including NES, will bind to the oriT and perform 
the transesterification reaction at the nic site to form the covalent complex. The components 
in the relaxosome will join with the coupling protein to allow NES to transfer the DNA into 
the recipient cell in a 5’ to 3’ direction. Once transfer is complete the 3’ hydroxyl on the 
transferred strand can attack the tyrosine-phosphate bond to recircularize the DNA. The host 
replication machinery will then duplicate the DNA so each will have double stranded 
resistance plasmids.  
Resistance  
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Figure 1.5  Schematic Diagram for the Proposed Catalytic Mechanism of NES 
 
The tyrosine residue of NES initiates a SN2 attack on the scissile phosphate between the 5’ 
guanine and 3’ cytosine of the nic site.  The hydroxyl is believed to be activated by a specific 
base such as an ordered water molecule. The HUH motif is shown coordinating a Ni2+ used to 
position the DNA for the cleavage reaction.  
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Chapter 2 
 The Structure of the NES Relaxase in Complex with DNA 
2.1 Introduction 
 The relaxase domain of NES was examined to elucidate its mechanism of DNA binding 
and cleavage during conjugative plasmid transfer (CPT).  Indeed, because relatively little detailed 
biochemical and structural work has been conducted on plasmid systems from Gram-positive 
bacteria, a central goal was to understand if the relaxase on pLW1043 interacts with DNA in the 
same manner as the relaxases found on other plasmids. The plasmid pLW1043 was found in a 
clinical VRSA strain; however, it is 99% identical to other, less virulent plasmids, including 
pGO1 and pSK41 that do not encode vancomycin resistance.  The NES genes from these three 
plasmids are identical in sequence. To date, the structures of the relaxases from the F plasmid 
(TraI), R388 (TrwC), pCU1 (TraI), and R1162 (MobA) have been determined 1-6. NES was 
predicted to contain only one functional tyrosine residue in the active site, similar to that observed 
for MobA. Prior to this work, only relaxases from the plasmids F and R388 (TraI and TrwC, 
respectively) with multiple redundant tyrosines had been determined in complex with DNA 1-4. 
By analyzing the differences in binding and specificity, the long-term goal of this project is to use 
potential subtle changes in structure to design specific inhibitors that can impede the function of 
the relaxase. An additional central objective is to learn more about the relatively under-studied 
Gram-positive conjugative process.  
 We determined the 2.9 Å resolution structure of the relaxase domain of NES (residues 1-
220) in complex with DNA containing 28 nucleotides including a hairpin and single-stranded 
region leading to the nic site. This represents the first structure of a single active site tyrosine 
relaxase in complex with DNA substrate. While the DNA was observed in the same general 
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orientation as seen in TrwC-DNA complex, the NES-DNA complex structure reveals some 
overall key differences, as well as more detailed distinctions. Previous relaxases have been 
described as having an overall architecture of a “hand” with the β-sheet core being the “palm” 
and the surrounding α-helices representing the “thumb” and “fingers” holding the DNA in place. 
We observed our enzyme was able to bind to the DNA substrate without this thumb feature as 
well as numerous differences in the residues that provide specificity for the DNA. Before the 
more detailed distinctions unique to the NES relaxase are outlined, the methods and results 
related to the characterization of NES will be described.  
2.2 Construct Design and Cloning of the NES Relaxase and Mutants 
 To determine the structure of the NES enzyme, multiple attempts at crystallization were 
made. Initially the full-length protein was used for crystallization trials, but significant 
degradation was found in the resulting crystals. (This will be covered in Chapter 4 when 
discussing the C-terminal domain structure.) The amino acid sequence of NES (GenBank: 
AE017171)	  was input in the Phyre server 7 and the relaxase minMobA was found to be the best 
sequence and structural match for N-terminal portion of NES. Analysis of the resulting alignment 
showed that the characteristic motifs of a relaxase were present and that NES should have a 
similar fold compared to MobA.  The structure of minMobA incorporated the N-terminal 186 
amino acid fragment of the enzyme. Primers were designed for the NES relaxase domain using 
the alignments to search for optimal places to end the fragment such as loops or disordered 
regions and 5 constructs were selected. Integrated DNA Technologies (IDT) commercially 
synthesized the primers and all cloning or mutagenesis was verified using Eton Biosciences Inc. 
The primers were diluted to 100 mM stock solutions in ddH20 and subsequently diluted to 10 mM 
working stock solutions. Standard ligation independent cloning techniques, as described by Stols 
et al. 8, were used to generate the expression plasmids encoding the desired NES fragments. The 
PCR amplified DNA fragments were inserted into empty pMCSG7-Lic and pMCSG7-Lic-MBP 
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vectors. The N-terminal His6 or His6 maltose-binding protein (MBP) tag was cleaved off after 
purification using tobacco etch virus (TEV) protease.  
 NES primers were also designed for incorporation into the CPD expression system that 
was generated in our lab by Joseph Lomino and Daniel Yao. The initial CPD expression system
described by Shen et al. 9 was modified through codon optimization, changing the hexa-his tag to 
a deca-his tag, and adding an longer glycine linker between the protein and cleavage site (CPD-
Lasso). Again, the primers were ordered from IDT, amplified, and cloned into the CPD-Lasso 
expression vector using the NdeI (5’) and BamHI (3’) restriction endonuclease sites. The 
constructs result in a C-terminal CPD-His10 tag on the protein that was cleaved using 2 mM 
inositol hexakisphosphate (InsP6) incubated for 3 hours at 4 °C.  
 All point mutations were done using site-directed mutagenesis in the corresponding 
expression plasmid. Again, sequencing for the mutations was confirmed using Eton Biosciences, 
Inc. for DNA sequencing.  
2.3 Expression and Purification of the NES Relaxase 
 The cloned constructs were transformed into chemically competent E. coli BL21 (DE3) 
AI cells. Transformed cells were grown in 1.5 liters of lysogeny broth (LB), in the presence of 
ampicillin, at 37 °C, with shaking, to an optical density of 0.6-0.8. An L-Arabinose solution was 
added to the growth at a final concentration of 0.2% v/v, and the temperature was reduced to 
18 °C for 30 minutes. Protein expression was induced with 100 µM isopropyl-β-D-
thiogalactopyranoside (IPTG) and cells were allowed to grow for 16 hours. The resulting growths 
were spun at 4,500 x g for 30 minutes at 4 °C and split into six pellets that were stored at -80 °C. 
Individual pellets were resuspended in nickel A buffer (500 mM NaCl, 25 mM imidazole, 20 mM 
potassium phosphate buffer pH 7.4, and 0.02% v/v sodium azide) along with protease inhibitor 
tablets (Roche), DNase, and lysozyme. The slurry was lysed using a Fischer Scientific Sonic 
Dismembrator at 50% power for 3 cycles of 1 minute with 1 second intervals at 4 °C. The lysed 
cells were then spun at 18,500 x g for 1 hour. The supernatant was filtered and purified over a 
	   17 
HisTrap column (GE Healthcare). None of the N-terminal His6 or His6 MBP constructs expressed 
solubly after the removal of the tag by TEV. For the CPD constructs they were allowed to bind to 
the HisTrap column and incubated with InsP6 for 3 hours at 4 °C. The resulting protein was then 
further purified over a Superdex 200 column (GE Healthcare) pre-equilibrated in sizing buffer 
(300 mM NaCl, 50 mM Tris buffer pH 7.4, and 0.02 % v/v sodium azide). Fractions containing 
NES 1_220, which was found to contain the functional and soluble relaxase domain of NES, were 
combined and used for site directed mutagenesis as well as the following experiments.  
 To obtain protein in complex with DNA an active site mutant Y25F was used. A piece of 
DNA with the sequence 5’-ACGCGAACGGAACGTTCGCATAAGTGCGCC-3’ was 
synthesized by IDT and used as the substrate. After nickel purification the DNA was added in a 
2.25 molar excess to the enzyme and size exclusion chromatography was performed for final 
purification. The presence of DNA was confirmed measuring the absorbance of A260/280 on a 
nanodrop (Thermo Scientific).  
2.4 Circular Dichroism and Dynamic Light Scattering of NES 1_220 
 Circular dichroism (CD) and dynamic light scattering (DLS) were used in conjunction to 
confirm that the protein was folded, stable, and monodispersed in solution. CD measurements 
were made on a Chirascan CD Spectrometer (AppliedPhotophysics) with the protein diluted into 
CD buffer (200 mM KF, 10 mM potasim phosphate buffer pH 7.4) to a concentration of 5 µM. A 
wavelength scan from 190-260 nm revealed a protein that was folded containing both α-Helices 
and β-Sheets. This was determined by the presence of a positive peak at 190 nm and a double 
negative peak at 208 and 225 nm. However, the double negative peaks were reduced as to what 
would be expected for only α-Helices and this can be attributed to the presence of β-sheets that 
have a negative peak at 215 nm which will affect the curves (Figure 2.2.A). The resulting 
ensemble of peaks made us believe that the protein was in fact folded and a combination of both 
sheets and helices which is predicted when comparing NES 1_220 to similar structures. Thermal 
denaturation was performed while monitoring the 209 nm wavelength that corresponded to the 
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most distinguishable peak from the wavelength scan. The melting temperature (Tm) was 
determined to be approximately 58 °C by observing where half of the protein was in a folded 
versus unfolded state from the data (Figure 2.2.B).  
 Dynamic light scattering (DLS) was performed on a Dynapro Dynamic Light Scattering 
Plate Reader (Wyatt Technology Corp.). Prior to measurement the samples were spun at 13,000 x 
g to ensure no dust or sediments would affect the measurement. The sample of NES 1_220 was 
measured at 10 mg/mL and showed a single monodisperse peak with a polydispersity of 10.7% 
and a radius of hydration of 2.6 nm (Figure 2.3). The molecular weight calculated from this 
reading was 33 kDa, larger than the actual molecular weight of 26 kDa for NES 1_220 but 
perhaps indicative of an elongated protein shape in the absence of DNA. Taken together, though, 
these data are representative of a well folded, stable, and pure protein.  
2.5 Crystallization, Data Collection, and Data Processing  
 Selenomethionine-substituted protein was used in crystal trials to obtain phase 
information upon data collection. NES 1_220 + DNA (10 mg/mL) was crystallized in a solution 
containing 16% PEG 8,000, 120 mM calcium acetate, 80 mM sodium cacolydate (pH 6.5), and 
20% glycerol v/v. The trays were set with drop ratios of 1:1, 1:2, and 2:1 of protein to mother 
liquor respectively. Vapor diffusion hanging-drop trays were set at 20 °C to obtain well formed 
crystals. The crystallization solution was found to be an adequate cryoprotectant in subsequent 
diffraction experiments performed at the UNC Biomolecular X-ray Crystallography Facility. The 
crystals were flash frozen in liquid nitrogen for data collection at 100K.  
 Data sets were obtained on the 23_ID_B beamline maintained by The National Institute 
of General Medical Sciences and National Cancer Institute Collaborative Access Team (GM/CA-
CAT) at the Advanced Photon Source (APS) part of the Biosciences Division (BIO) at Argonne 
National Laboratory (ANL). A fluorescence scan was performed at the selenium absorption edge 
to confirm that the seleno-methione substitution was successful. The collection strategy used 
included 1-second exposures with a 1° rotation between frames and inverse beam every 10° to 
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collect 100° of data. The data sets were indexed and scaled using HKL-2000 processing software 
10. Indexing resulted in resulted in a space group of P6422 with one NES relaxase-DNA complex 
per asymmetric unit. The best data was obtained when the resolution was cut to 2.9 Å (Table 2.1). 
Initial phases were determined using the Phenix software suite with the AutoSol function 11. Two 
of the three heavy atom sites were successfully located. This was a result of the first amino acid, 
methionine, not being observable in the final structure, most likely as a result of it being 
processed away during expression as was seen in the MobA structure 5. The model was built 
using Coot 12 by placing the seleno-methiones and iteratively building the protein from these 
starting points. Refinements were performed using the Phenix refine application 11.  
2.6 Analysis of the NES Relaxase in Complex with DNA Structure 
2.6.1 The Overall Fold of the Relaxase Domain NES 
 One NES relaxase-DNA complex was observed per crystallographic asymmetric unit, 
indicating that the enzyme interacts and functions with the DNA as a monomer, a conclusion 
supported by size exclusion chromatography studies (data not shown). The residues 2_196 of 
NES 1_220 were built into the electron density. The terminal methionine was most likely 
processed away during expression and the 24 C-terminal residues are at the end of a loop that is 
likely disordered in this construct. Additionally, the 5’ DNA adenine and the two 3’-terminal 
cytosine bases were not visible in the electron density. The overall fold of NES 1_220 was similar 
to the other relaxases studied in regard to the active site and position of the catalytic tyrosine. As 
seen in Figure 2.1, the core of the enzyme is composed of 5 central anti-parallel β-strands. The 
remaining two β-strands and four α-helices are structural elements and position the catalytic 
tyrosine for nucleophilic attack. The two DNA binding loops clamp on either side of the hairpin 
for proper substrate recognition and positioning. The central β-sheet is ordered β1-β5-β7-β6-β4 
when looking down into the active site of the molecule. The HUH motif (H131 and H133) is 
found at the beginning of β7 and the third H (H123) is located at the 3’ end of strand β6. This 
motif is conserved in relaxases and coordinates the metal ion at the active site.  The catalytic 
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tyrosine is located on α1 in an orientation that would allow it to perform its nucleophilic attack on 
the scissile phosphate at the nic site. Ni2+ was built into the density adjacent to the chelating 
histadine residues, as it was clear there was a metal bound from the difference density maps; 
additional ICP-MS data indicated this metal was Ni2+ and was most highly incorporated after 
purification over the Ni-resin (data not shown). However, H131A mutants were made to disrupt 
the metal chelation site in the HUH motif and the Ni2+ concentration was significantly reduced 
(data not shown). From Figure 2.1, it is clear the single stranded stretch of the DNA curves 
around the enzyme and is held in a U turn conformation where it would be possible for the 
nucleophilic attack to occur from the oxygen on the catalytic tyrosine. In the structure one can see 
that the 3’ guanine appears to be flipped away from the active site. This was due to a crystal-
packing defect where the 3’ cytosine (C27) and guanine (G28) bases stacked with the 
corresponding 3’ terminal bases in another molecule in the crystal (Figure 2.4). 
 Secondary structure alignments comparing NES to the other relaxase structures reveal 
some key differences between the enzymes. Figure 2.5.A compares the structure-annotated 
sequences of NES_220 to MobA (PDB: 2NS6), F TraI (PDB: 2A0I), TrwC (PDB: 1QX0), and 
pCU1 TraI (PDB: 3L57). The structures were aligned using DaliLite 13-15 for pairwise comparison 
of the protein structures. When the relaxase domain of NES was aligned to MobA, the RMSD 
was 2.2 Å over 162 equivalent Cα positions, and 28% sequence identity was observed. The 
RMSDs for F TraI, TrwC, and pCU1 TraI were all 3.1 Å over 158, 155, and 153 equivalent Cα 
positions, respectively, with 10%, 8%, and 5% sequence identities, respectively. Despite the 
relatively low sequence identity between structures, especially for the latter three, there were 
significant similarities in the overall fold. As mentioned previously, the secondary structure 
elements are arranged in an analogous fashion for all of the enzymes aligned. For example, the N-
terminus is located at the beginning of β1, the first strand in the “palm” of the hand. α1 is 
conserved in all structures; however, the catalytic tyrosine is present on the helix in NES, MobA, 
	   21 
and F TraI, while in TrwC and pCU1 TraI the catalytic tyrosines are present on the loop between 
α1 and β4 in Figure 2.5.A. This may be due to the fact that the enzymes with multiple tyrosines 
have functional redundancy, and by placing such tyrosines in loops, mobility can be enhanced.  In 
NES exclusively, there is a short loop containing β2,3 before reaching the conserved β4 which 
forms the outer edge of the other side of the “palm”. α3 is highly conserved in all of the aligned 
structures, is located at the top of the beta-sheet core, and is responsible for positioning hairpin 
loop 1 that interacts with the DNA substrate in NES. The loop between α3 and β5 is variable 
between the structures and will be discussed in the next section. Again, β5 is highly conserved, as 
it is part of the central core of the enzyme. F, TrwC, and pCU1 have an extra helix at the base of 
the β-sheet core where NES and MobA only contain the conserved α4. Another difference 
between NES and MobA, though, when compared to other structures is the presence of a loop 
containing two short β-strands between α4 and β6. This loop is responsible for interacting with 
the minor groove of the DNA substrate as seen in the structure of TrwC and NES in complex with 
DNA and will be discussed in more detail in the next section. β6 and β7 are highly conserved, as 
they are the final two strands present in the β-sheet core. Another major difference can be seen 
between β7 and α5 in Figure 2.5.A. In both NES and MobA there is a long loop that interacts 
with the DNA hairpin. In the other three, this loop is shorter and contains two small β-strands. 
Finally, α5 is highly conserved in all of the structures and packs against α4 to form the back of 
the enzyme. The subtle differences that were found when comparing the hairpin Loop1 and 
Loop2, as well as the interactions with the single stranded stretch of the DNA substrate, explain 
how these enzymes are able to achieve specificity for their specific substrates, as outlined below.  
2.6.2 Structural Elements for the Recognition of the DNA Substrate 
 The DNA substrate has extensive interactions with the relaxase that are centered on the 
two major DNA regions – the hairpin and the stretch of single-strand. Interestingly, the majority 
of the interactions are found to be at the base of the hairpin and the section of single-strand DNA 
closest to the hairpin (Figure 2.5.B). The hairpin present at the 5’ side of the oriT has extensive 
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interactions with two loops in NES 220 termed Hairpin Loop1 and Hairpin Loop2 (Figure 
2.5.A,B). The single-stranded portion of the DNA interacts primarily with key residues found on 
α5 and β1. In F TraI and TrwC, there are extra α-helices present at the C-terminus that interact 
with the single stranded portion of the DNA, acting as a ‘thumb” clamping it in place 16. These 
helices are not present in the smaller, single-tyrosine relaxases NES and MobA. After the nic site, 
we speculate that the single-strand of DNA would continue over the active site and be held in 
place through interactions with α1, β2, β3, and the loop between the β-strands in NES 220. 
 Each enzyme will have direct interactions along the single-stranded portion of the DNA. 
These interactions will be specific to the DNA sequence, how the bases are presented to the 
enzyme will confer specificity. Figure 2.6 illustrates how two bases on the single stranded portion 
(Ade20 and Thy21) are exclusively recognized by the DNA bases present, while no interactions 
occur with the phosphate backbone. Q82 and Y156 form the hydrogen bond network that 
recognizes Ade20. N8 and R85 are hydrogen donors for the carbonyl oxygen on Thy21. Not all of 
the bases on the single stranded portion make interactions with the DNA, for example Ade24 and 
Gua25. Specific bases that do interact with the enzyme have been studied through mutational 
analysis and will be discussed in the next chapter.  
More surprising was the finding that the loops responsible for binding the hairpin portion 
of the DNA (Figure 2.7) are vastly different between the two sets of enzymes, NES 220, MobA 
vs. F TraI, TrwC, pCU1 TraI. When comparing the loops that interact with the DNA hairpin 
portion of the substrate it is necessary to look at the enzymes in the two different groups 
mentioned above. This is because the DNA hairpin structures are significantly different between 
the two groups. Currently only two structures of relaxases in complex with the DNA hairpin 
portion of the substrate have been determined, TrwC and NES 220. When comparing NES 220 + 
DNA to the MobA structure, two major differences can be seen. Figure 2.8 depicts the alignment 
for NES and MobA (RMSD 2.2 Å). In Figure 2.8.A the major difference arises in the β2, β3 
region of NES. This is the area of the protein where we believe the 3’ side of the nic site would be 
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positioned by the enzyme. When NES interacts with the DNA this portion of the enzyme might 
order to form the β-strands from the small α-helix that is seen in the MobA structure (Figure 
2.8.A). This would allow the enzyme to maintain tight contact with the covalently bound portion 
of the enzyme during substrate transfer into the recipient cell. Another significant change in the 
enzyme architecture can be observed when looking at the interactions made with the DNA that 
can be observed from the NES 220 structure. Figure 2.7 depicts the two key loops that clamp the 
DNA hairpin in order to bind the substrate. Loop1 interacts with the minor groove that is formed 
in the hairpin while the longer Loop2 interacts with the major groove (Figures 2.5.B, 2.7). These 
loops have extensive hydrogen bond interactions with both the phosphate backbone as well as a 
few key bases. Loop1 is in an almost identical position in both the MobA and NES structures. 
However, Loop2 has a significantly different conformation when bound to DNA. In the NES 
structure Loop2 is a long loop that packs into the major groove of the DNA acting as one side of 
the clamp. In the MobA structure this loop forms two short α-helices and is positioned in the open 
conformation (Figure 2.8.B). One can imagine that when the DNA comes into position on the 
enzyme the α-helices rearrange into loops, and the new conformation will be stabilized through 
interactions with the DNA forming the double sided clamp that holds the substrate in place for the 
attack at the nic site.  
 When comparing NES to TrwC, the larger relaxase construct, more differences can be 
noted. In the comparison of the overall structural alignment (Figure 2.9) the “thumb” region of 
TrwC is the first noticeable difference. This region is not present in the NES construct and could 
either be due to the fact that the construct crystallized for NES was not long enough to observe 
this region, the C-term may perform the thumb function in NES, or the thumb region regulates the 
action of the multiple catalytic tyrosines since it is only present on those enzymes. The 
biochemical data discussed in the next chapter would seem to rule out the second point as this 
portion of the enzyme is able to specifically bind this substrate with low nanomolar affinity and is 
functional. However, this region is present in both TrwC and F TraI and may play a role in adding 
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specificity or binding efficiency for those enzymes. Another difference, noted in MobA as well, is 
the β2, β3 region of the enzyme. As mentioned previously, this structural arrangement will most 
likely be dependent on the substrate sequence and has not been thoroughly investigated. Figure 
2.5 highlights the significant sequence and structural divergence that occurs in the hairpin Loop1 
and Loop2 regions in TrwC and NES. The differences can be seen in the structures presented in 
Figure 2.10, however they have been separated for visual simplicity. Figure 2.10.A shows the 
Loop1,2 interactions that were previously discussed for NES. When comparing that to TrwC, 
Figure 2.10.B, significant differences can be observed both in the enzyme secondary structure as 
well as the DNA hairpin conformation. In TrwC, Loop1 is significantly longer and across the face 
of the minor groove interacting with both the phosphate backbone as well as the DNA bases. 
Loop1 in NES also interacts with the minor groove in the same fashion but is much shorter in 
length. In TrwC the hairpin appears to be squished leading to a shorter and less well defined 
minor groove. Loop2 in both constructs interacts with the DNA in a similar fashion despite the 
structural differences. In NES Loop2 interacts with the DNA backbone along the left side of the 
loop. The loop winds its way into the major groove where base specific interactions occur. 
Despite the significant structural and sequence divergence TrwC interacts with the DNA in the 
same manner. The β-strand on the left side of Loop2, Figure 2.10.B, interacts with the DNA 
backbone while the loop that makes the turn to the next β-strand makes some specific base 
interactions. Furthermore, both loops interact with the 5’ terminal portion of the substrate. 
2.7 Conclusions 
 By determining the structure of NES 220 in complex with DNA we were able to make 
some interesting structural observations. Firstly, we are the first group to report the structure of a 
single tyrosine relaxase in complex with DNA. This result will be critical for our analysis of the 
DNA binding and cleavage specificity in the following chapter as well as for our efforts to 
develop novel antibiotics. The overall fold of this structure was similar to all other relaxase 
structures determined to this date. The central β-sheet core is consistent with the known 
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architecture and the main differences arise due to key loops required for DNA binding. In the 
case of NES and MobA the DNA results in subtle conformational changes between Hairpin 
Loop1 and Loop2 to allow for the binding of the substrate to the enzyme. When looking at the 
structures found in the TrwC group of enzymes more drastic differences were observed. Again, 
despite significant lack of sequence homology there was maintenance of the enzyme core. 
However, the loops required for hairpin binding achieve the same end goal while being in 
completely different conformations. These differences lead to proper substrate recognition and 
provide novel sites to design specific compounds that could inhibit the enzyme-substrate 
interaction that could result in the development of novel antibiotics. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
	   26 
Data Collection 
X-ray source APS ANL  GM/CA-CAT 
Space Group P 64 2 2 
Unit cell: a,b,c (Å); α,β,γ (°) 63.2, 63.2, 313.8; 90, 90, 120 
Wavelength (Å) 0.95471 
Resolution (Å) (highest shell) 48.5-2.90 (2.95-2.90) 
I/σ 47.9 (5.96) 
Completeness (%) 97.7 (79.7) 
Redundancy 20.3 (13.2) 
Refinement 
Resolution (Å) 48.5-2.90 
No. reflections (unique) 8782 
Rwork 22.6 
Rfree 28.5 
Molecules per asymmetric 
unit (AU) 1 
No. of amino acids per AU 
(DNA nucleotides) 195 (27) 
No. of waters per AU 43 
Average B-factors (Å2) 60.8 
R.M.S. deviations (Å) 2.08 
Bond lengths (Å) 0.008 
Bond angles (°) 1.407 
Ramachandran (%) 
Preferred 96.3 
Allowed 3.7 
Outliers 0.0 
Table 2.1 Crystallographic Statistics 
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Figure 2.1 Structure of NES 1_220 in complex with DNA 
 
The 2.9 Å crystal structure of NES 220 in complex with DNA. The N-term and C-term 
amino acids are labeled as well as the 5’ and 3’ nucleotides. The α-helices, β-strands, and 
hairpin loops are labeled by the order in which they appear in the sequence. α2 is hidden 
behind α3. The side chains for the HUH(+H) motif and the catalytic residue are shown.  
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Figure 2.2 Circular Dichroism Analysis of NES 220 
 
A. CD wavelength scan of NES 220 at 5 µM. B. Thermal denaturation of NES 220 
monitoring the change in CD signal (mdeg) at 209 nM.  
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Item   R (nm)     %Pd     MW-R (kDa)    %Int       %Mass  
Peak 1      2.6       10.7           33      100.0       100.0 
Figure 2.3 Dynamic Light Scattering of NES 1_220 
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Gua28 
Gua28 
Cyt27 
Cyt27 
Figure 2.4 Crystal Packing Effect on the 3’ End of the DNA Substrate 
 
Two symmetry mates from the crystal packing are depicted in green and cyan. Highlighted 
above it is clearly visible that the DNA is being pulled out of the active site. The inset depicts 
the Watson-Crick base paring interactions for the each molecule’s terminal DNA bases.  
 
 
31 
 
 
 
 
 
NES_220         myhfqnkfv-skangqsataksaynsasrikdfkenefkdysnkqcdyseillpnnaddk 
MobA            iyhltaktgs--ggqsarakadyiqregk----------yardmdevlhaesghmpefve 
 
F TraI          ----msiaqvr-----sagsagnyytdkdnyyvlgsm----------gerwagrgaeqlg 
TrwC DNA        ----lshmvltrqdigraasyyedgaddyyakdgda------------sewqgkgaeelg 
pCU1 TraI       ----ldittitrqnvtsvvgyysdakddyyskdssf------------tswqgtgaealg 
  
 
 
                                        HAIRPIN LOOP1 
 
 
NES_220         fkd--reylwnkvhdve-------------nrknsqvareiiiglpnefd---------- 
MobA            ----rpadywdaadlye-----------rangr---lfkevefalpvel----------- 
 
F TraI          lqgsvdkdvftrllegrlpdgadlsrmqdgsnrhrp-gydltfsapksvsmmamlggdkr 
TrwC DNA        lsgevdskrfrellagnigeghrimrsatrqdskerigldltfsapksvslqalvagdae 
pCU1 TraI       lsgdvesarfkellvgeidtfthmqrhvg-dakkerlgydltfsapkgvsmqalihgdkt 
                                                                             
 
 
 
 
 
NES_220         -pnsnielakefaeslsnegmi------------------vdlnihkineenp---hahl 
MobA            tldqqkalasefaqhltgaerlp-----------------ytlaihaggge---nphchl 
 
F TraI          lidahnqavdfavrqv-ealastrvmtdgqsetvltgnlvmalfnhdtsrdqepqlhtha 
TrwC DNA        iikahdravartleqae-araqarqkiqgktriettgnlvigkfrhetsrerdpqlhtha 
pCU1 TraI       iieahekavaaavreae-klaqarttrqgksvtqntnnlvvatfrhetsraldpdlhtha 
 
 
            
                                                               HAIRPIN LOOP2 
 
 
NES_220         lctlrgldknnef------------------epkrkgndyirdwntkekhnewrkrwenv 
MobA            miserindgierpaaqwfkryngktpekggaqkt------ealkpkawleqtreawadha 
 
F TraI          vvanvtqhngewk------------------tlssdkvgkt-gfienvyanqiafgrlyr 
TrwC DNA        vilnmtkrsdgqw------------------ralk------ndeivkatrylgavynael 
pCU1 TraI       fvmnmtqredgqw------------------ralk------ndelmrnkmhlgdvykqel 
 
 
 
 
 
 
NES_220         qnkhlekngfsvrvsadsy                     Beta Strands 
MobA            nraleragh----------                     Alpha Helix 
 
F TraI          eklkeqvealgyetevvgk 
TrwC DNA        ahelqklgyqlrygkdgnf 
pCU1 TraI       aleltkagyelrynsknnt 
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Figure 2.5.A Secondary Structure Alignment 
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ACGCGAACGGAACGTTCGCATAAGTGCGCC 
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Figure 2.5.B Protein Residue Interactions with the DNA Bases 
 
The DNA substrate is shown in the 5’ to 3’ direction with the hairpin section underlined and 
the nic site indicated by the triangle. Protein residues colored red indicate interactions via the 
DNA phosphate backbone. Protein residues colored green indicate interactions via the DNA 
bases.  
N129 
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Figure 2.6 Single Strand DNA Base Specific Interactions 
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Figure 2.7 NES Hairpin Loop Interaction with the DNA Hairpin 
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Figure 2.8 Comparison of NES 220 to MobA 
Loop2 MobA 
36 
NES 220 
TrwC 
Thumb  
Region 
β2, β3  
Figure 2.9 Comparison of NES 220 to TrwC 
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Figure 2.10 Comparison of NES 220 to TrwC – DNA Hairpin Regions 
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Chapter 3 
DNA Binding and Nicking Analysis of the Relaxase Domain of NES  
3.1 Introduction to Relaxase Function 
 As mentioned previously, relaxases are an integral part of the relaxosome allowing for 
the initiation and termination of CPT 1. The relaxosome is the set of proteins that are responsible 
for processing the DNA, joining with the coupling protein, and allowing the transfer of the DNA 
into the recipient cell 2. In order for consistent CPT the relaxase must be able to recognize the 
DNA substrate at the oriT and cleave exclusively at the nic site. This requires a high affinity and 
sequence specific interaction to ensure the cleavage reaction occurs at the correct site, every time, 
during CPT. All relaxases studied to date have high affinity, sequence specific interactions with 
their DNA oriT regions except for TraI of pCU1 3. Through investigating the DNA binding 
characteristics and determining the specific base interactions with the protein we hoped to gain 
two main pieces of information. The first would be to determine the optimal substrate for use in 
X-ray crystallization trials. This would improve our chances of obtaining the structure of NES 
220 in complex with DNA. The rational being that if we can find the highest affinity, shortest 
ligand we will have the best chance of ensuring the enzyme is in complex with DNA in the 
crystal. The second is to learn more about how NES, a gram-positive plasmid relaxase, 
recognizes and binds to the DNA. This information will be useful by aiding the field in 
understanding the subtle differences found between relaxase’ recognition of DNA and to provide 
a map of key DNA bases that can be explored as novel drug targets. Through understanding 
which DNA bases interact with NES, we can focus our efforts on developing strategies or 
compounds that can impede the ability of NES to bind DNA, and hopefully disrupt CPT.  
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 Another long-standing question in the field is to determine which divalent cation is 
actually used in vivo for the transesterifcation reaction. Although we do not answer that question 
here, we have analyzed the divalent cation preference in vitro, determined the actual nic site for 
NES through cleavage assays, and looked at the effects of mutations and metals on the cleavage 
reaction. Mutant forms of NES designed from the structure, as well as mutant DNA oligos, were 
analyzed to shed light on the specific role certain segments of the enzyme play in the reaction. 
Taken together, these data will allow us to understand the effects of mutations and provide a 
system to test novel inhibitor efficacy.  
3.2 Construct and Oligonucleotide Design, Mutagenesis, Expression and Purification 
 The relaxase domain of NES, NES 220, was cloned and purified as previously mentioned 
in Chapter 2. Briefly, all constructs in the following work were cloned and expressed into the 
CPD-Lasso expression vector using the NdeI (5’) and BamHI (3’) restriction endonuclease sites. 
All mutations were made by site directed mutagenesis and sequences were confirmed by Eton 
Biosciences, Inc. The resultant cloned proteins or mutant variants were purified in the same 
fashion as used in crystallization trials. After HisTrap and size exclusion chromatography the 
pure fractions were combined, flash frozen in liquid nitrogen, and frozen in stocks stored at -
80 °C for use in experiments.  
 Integrated DNA Technologies (IDT) manufactured oligonucleotides for binding and nic 
assays. The oligos were designed based on the sequence for pLW1043 (GenBank: AE017171) 
around the oriT that was identified based on sequence comparisons to pSK41 and pGO1 4,5. 
Oligos used in direct binding experiments were labeled with a 5’ 6-FAM fluorescein and HPLC 
purified for fluorescence anisotropy experiments. All oligos used in binding or nic assays were 
diluted to 100 mM in oligo annealing buffer (50 mM NaCl, 0.05 mM EDTA, 10 mM Tris pH 7.5). 
The oligos were then annealed by bringing them to 95 °C for 10 min. and lowering the 
temperature by 1 °C each min. until 4 °C was reached using a thermocylcer (Eppendorf). The 
annealed oligos were then diluted to 10 mM working stocks in the oligo annealing buffer. 
	   42 
Annealing was done to ensure the proper formation of the hairpin duplex present on some of the 
oligos.  
3.3 DNA Binding Data Introduction 
 We wanted to learn more about the specific DNA substrate that is recognized by NES 
during CPT in order to determine which bases are responsible for recognition, what DNA 
structural elements are required, and what the minimal length of the substrate is necessary. For 
other relaxases studied, it has previously been shown that these enzymes bind a portion of the 
transferred strand (T-strand) at a specific location called the oriT. They will then cleave the 
substrate at the specific nic site to begin transfer 3,6-8. Obtaining this information for NES aided us 
in identifying the optimal crystallization substrate as well as learning more about the recognition 
characteristics of the enzyme. In order to truly observe the binding characteristics of the enzyme a 
catalytically dead mutant (Y25F) was used in the experiments. This would ensure that no 
secondary effects due to cleavage and religation of the substrate were interfering with the 
measurements. Once the binding affinity for the initial oligo was determined, competition assays 
were employed to probe the effects of shifting the sequence base by base, shortening the sequence, 
or removing the hairpin. Upon obtaining the crystal structure, mutations were made to the enzyme 
based on the structural analysis to investigate critical residue-DNA base interactions.  
3.3.1 Methodology 
 DNA Binding Studies – Direct Binding. In order to determine if in fact our relaxase bound 
in a specific, high affinity fashion we employed fluorescence anisotropy to measure the binding 
interaction. NES 220 and NES 220 Y25F were used to determine the dissociation constant, KD, 
for the initial probe used. The annealed DNA oligo selected for the initial experiments had the 
sequence 5’ 6-FAM-ACGCGAACGGAACGTTCGCATAAGTGCGCC 3’ which incorporated 
the full inverted repeat and the 5’ side of hypothesized nic site (terminal C base). For each assay, 
purified protein was diluted to 2X maximal assay concentration into a buffer of 150 mM NaCl, 
0.1 mg/mL bovine serum albumin (BSA), 5 mM Mg2+ Acetate, 25 mM Tris Acetate pH 7.5. The 
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protein stock was then serial diluted into 40 µL of the final reaction buffer 100 mM NaCl, 0.1 
mg/mL BSA, 5 mM Mg2+ Acetate, 25 mM Tris Acetate pH 7.5. This was done in a 384-well 
black assay plate (Costar) to generate 16 concentrations of protein, 8 dilutions from 500 nM 
protein and 8 from 400 nM protein. The DNA probe was diluted to 5X final assay concentration 
into the reaction buffer. 10 µL of the DNA stock solution was added to the 40 µL resulting in a 
final concentration of DNA probe at 50 nM, 1X protein, and a total volume of 50 µL in each well. 
The no-protein control well was generated by adding 10 µL of DNA to 40 µL of reaction buffer.  
 Fluorescence anisotropy (FA) was employed to measure the dissociation constant for the 
DNA oligo. The FA of the fluorescently-labeled substrate at 520 nM was measured following 
excitation at 485 nM using a PHERAstar plate reader (BMG Labtech) in a T format. 
Measurements were made in triplicate and the normalized data was plotted as average FA vs. 
protein concentration. Equation 3.1 was used to fit the data using Graphpad PRISM v5.03 
(Graphpad, 2010) and calculate the KD for the substrate. 
Equation 3.1: 
! = !"# + !"# −!"# ! + ! + ! − −! − ! − ! ! − 4!" !!2!  
Where f, average FA signal detected; T, total DNA concentration (set to 50 nM); x, total protein 
concentration; K, KD; min, average FA signal of no protein control; and max, average FA signal 
of sample at saturating concentration of protein. A single binding site was assumed and all 
experiments were run in triplicate with standard error reported for each measurement.  
 DNA Binding Studies – Competition. To determine the effect of altering the DNA 
substrate sequence DNA competition assays were employed. Again, fluorescence anisotropy was 
measured, this time to determine the effect of unlabeled competitor oligos on the dissociation 
constant of the substrate used in the direct binding studies. The assay was setup in a similar 
fashion to the direct binding studies except the protein and labeled DNA oligo were held constant 
while the unlabeled competitive oligo was titrated. The same 384 well assay plate was used in the 
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experiment. The final reaction buffer was the same (100 mM NaCl, 0.1 mg/mL BSA, 5 mM Mg2+ 
Acetate, 25 mM Tris Acetate pH 7.5) with the addition of the labeled DNA oligo at 62.5 nM. The 
labeled DNA oligo was also added to the unlabeled stock of competitor oligo at 125 nM so that 
the concentrations were not affected during titration.  The maximal 2X concentration for the 
competitor oligo was 20 µM. As in the direct binding experiments, 40 µL of the final reaction 
buffer was placed in each of the 16 wells. For the competition experiments, 40 µL of the 
competitor olio was sequentially titrated down to the final concentration. The final well contained 
the no-protein control that only contained reaction buffer, labeled, and un-labeled competitor 
oligo. Lastly, 10 µL of protein at 5X reaction concentration was added to the wells. This resulted 
in an assay with 100 nM protein, 50 nM labeled DNA oligo, and a titration of competitor oligo 
concentrations from 10 µM to 0. Reductions in anisotropy were measured using the PHERAstar 
plate reader (BMG Labtech) in a T format. Measurements were made in triplicate and the 
normalized data was plotted as average FA vs. log protein concentration. Equation 3.2 was used 
to fit the data using Graphpad PRISM v5.03 (Graphpad, 2010) and calculate the IC50 for the 
competitor. 
Equation 3.2 ! = !"# + !"# −!"# / 1 + 10 !!!"#!"!"  
Where f, average FA signal detected; x, competitive oligo concentration; LogIC50, the 
concentration at which the maximal signal has decreased by half; min, average FA signal of no 
protein control; and max, average FA signal of sample at saturating concentration of protein. 
Once the IC50 has been determined it can be used in the following equation to determine the 
dissociation constant for the inhibitor (Ki) using equation 3.3. 
Equation 3.3 
!! = ! !"/ ! !"!! + ! !!! + 1  
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Where Ki, dissociation constant for the inhibitor, [I]50, concentration of free inhibitor at 50% 
inhibition, [L]50, concentration of free labeled ligand at 50% inhibition, [P]0, concentration of free 
protein at 0% inhibition, and Kd, dissociation constant of the protein-ligand complex 9,10. All 
experiments were run in triplicate with standard error reported.  
3.3.2 DNA Binding Sequence and Mutation Results 
 The first step in investigating the sequence requirements for NES to bind the DNA 
substrate was to confirm it specifically bound the oriT as would be expected for a relaxase. 
Fluorescence anisotropy was employed to determine the dissociation constant for the selected 
substrate. The initial DNA substrate was chosen based on sequence alignment to the pGO1 and 
pSK41 plasmids that had known oriT sites and were identical to plw1043 in this region 11. The 
substrate contained a 5’ 6-FAM fluophore attached to the inverted repeat (IR) hairpin, the single 
stranded portion of the DNA, and the 5’ cytosine of the hypothesized nic site (Table 3.1, Oligo 1). 
The nic site for NES was currently unknown and hypothesized to cut at that specific site based on 
sequence alignments to plasmids with the same sequence at the oriT. A catalytically inactive 
mutant, Y25F, of NES was used to ensure only binding interactions were measured. Five 
individual experiments run in triplicate were used to determine the initial affinity for the substrate. 
The data presented in Figure 3.1.A shows there was a high affinity interaction with a KD of 18.24 
nM ± 2.71. To confirm that this interaction was specific to the substrate used, a control 
experiment was run using a randomly generated sequence of the same length without the hairpin 
as well as a random sequence that contained an IR hairpin with a different sequence (Figure 
3.1.A.B). The results demonstrated that the recognition of the substrate by NES was due to the 
specific sequence and the length or hairpin structure are not enough for the enzyme to bind the 
substrate.  
 Next we wanted to determine the specific part of the plasmid sequence that is required for 
efficient binding and recognition and if there were any sites upstream or downstream of the 
sequence initially used. To do this we employed a competition assay using our reference substrate 
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as the fluorescent ligand and ordered a set of oligos that maintained the same length but varied in 
sequence. The sequence was started upstream of the hairpin and sequentially shifted 3’ by a 
single base until past the nic site (Table 3.1, Oligos 2-9). By determining the Ki for the 
competitors we would then be able to tell if there were other sites on the sequence that were 
recognized better by NES. Figure 3.2 shows representative binding curves for a competitor that 
has a weak affinity for NES (A) compared to a substrate that is an efficient competitor with the 
fluorescent probe (B). As seen in previous work with other relaxases, we found that the presence 
of the hairpin, the single stranded section, and the nic site were required for binding. Oligo 2 in 
Table 3.1 has a Ki ~17 fold weaker than our reference substrate. Any oligos shifted further in the 
5’ direction had even weaker affinities until no binding was detected. Oligos 3-6 have an increase 
in affinity as the sequence is shifted in the 3’ direction. This demonstrates that as we maintain the 
hairpin structure and extend the length of the single stranded DNA 3’ of the hairpin, the enzyme 
is interacting with those bases preferentially. Oligo 6 has the highest affinity for the NES relaxase 
and it incorporates the full-length hairpin, the single stranded DNA up to the nic site, the 
hypothesized nic site, and 3’ thymine after the nic site. As the sequence continues to shift 3’ in 
oligos 7-9 it can be seen that the hairpin is now affected. By shortening and finally disrupting the 
hairpin the affinity decreases. Any oligos shifted further than 9 showed no significant DNA 
binding.  
 Next we were curious to know if a shorter DNA oligo would be suitable as a substrate for 
NES. We decided to truncate the competitor oligos from both the 3’ and 5’ ends of the DNA. 
These results are presented in Table 3.1 (Oligos 10-16). From these results it is clear that 
truncating the construct from the 5’ side, and thus disrupting the hairpin, greatly reduces the 
enzyme’s ability to bind the substrate as seen in oligos 10-12. Interestingly, truncation from the 3’ 
side of the substrate did not initially have much of an effect. NES still has a specific and high 
affinity interaction with oligo 13.  This result will be discussed further in the following results 
section. The subsequent truncations from the 3’ end result in a decreased binding affinity. These 
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data confirm that a structurally intact hairpin and a single stretch of DNA that is at least 9 bases 
long must be present for NES to efficiently recognize the substrate. From these data, we chose to 
select oligo 4 for use in crystallization trials because it has a high affinity (8 nM), had some 
protection bases for the 6-FAM 5’ to the hairpin, and contained half of the hypothesized nic site.  
 Using the same competition assay we designed a set of 93 oligonucleotide competitors 
that contained DNA base mutations to further explore the specific bases required for the 
interaction between NES and the DNA. Oligo 4 from Table 3.1 was used as the template and each 
bases was mutated to one of the other 3 DNA bases. When the hairpin was involved the bases on 
each side of the duplex were mutated to ensure the hairpin could still form. A mutant hairpin was 
also designed that maintained the 3’ sequence of the hairpin but disrupted the 5’ sequence so that 
hairpin formation was not possible. This was done to determine if the base interactions were 
specific to one side of the hairpin or the structure of the hairpin was required for binding. Another 
set of mutations was made on a longer template that extended 6 bases 3’ of the nic site. Mutations 
were made in this area to see if the DNA following the nic site played a significant role in binding.  
 For simplicity only a select set of the data have been presented in Table 3.1 because not 
all of the mutations had interesting effects on the binding characteristics. As discussed previously 
in Chapter 2 (Figure 2.5.B) there are specific DNA bases that make interactions with NES. Oligo 
17 is a hairpin mutant that disrupts the 5’ side of the sequence with random bases that will not 
allow duplex formation. The Ki for this construct is ~33 fold weaker than for the oriT reference 
probe confirming again that the sequence and secondary structure of the oriT are required for 
efficient binding.  
 The biochemical data was collected prior to obtaining the structure of NES in complex 
with DNA so no inferences could be made as to which bases would be key in the interactions. By 
looking at the resultant Ki values that were determined for each mutant competitor there was a 
clear pattern that emerged. Firstly, there was no significant effect on the enzymes ability to bind 
the DNA when mutations were made to the terminal 8 bases on the 3’ end of the construct. This 
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agreed well with Figure 2.5.B that was determined from the structure. As seen in that figure, there 
are almost no interactions with the DNA bases on this portion of the DNA except for Gua26. We 
were surprised when we looked at the structure and saw the confirmation of the base at position 
Gua26 as it is protruding directly into an enzyme pocket and has numerous base specific contacts 
with NES (Figure 3.3). However, since guanine is the bulkiest base being a purine it is possible to 
imagine that substitutions into this pocket may not maintain the hydrogen-bonding network but 
will not clash with the enzyme residues. Furthermore, given that the base will still be able to fit 
into this cleft it is foreseeable that all of the other correct contacts will be maintained along the 
DNA substrate leading to efficient binding of these mutant oligos. An abasic site was designed 
into the oligo at this position and the effects will be discussed in the cleavage assay results section 
below. However, the biochemical data seem to agree with the structural analysis implying that the 
eight 3’ bases only contribute to binding through being present and not being dependent on the 
specific base sequence.  Another region on the DNA substrate that did not affect the enzymes 
ability to bind the substrate was the stem loop region present on the top of the DNA. When bases 
were inserted into this region (Table 3.1, Oligo 30) or mutation to the three unpaired bases were 
made (data not shown) the enzyme was able to bind with high affinity. 
 Mutations made 5’ of the Ade23 began to have significant effects on the enzymes ability 
to bind the DNA. When the bases from Cyt17 to Ade22 were mutated almost every mutation 
decreased the enzymes ability to bind by at least 4-fold with some being much as ~ 235-fold 
worse. The lone exception in this region was when mutations were made to Gua3 and Cyt19 at 
the base of the hairpin. As seen in Figure 2.5.B there are two interactions made with the protein 
but one of them is a main-chain hydrogen bond. The bases around Cyt19 have extensive 
interactions with the enzyme, including multiple base specific interactions, and may compensate 
for the loss of this one interaction from the mutation.  
 Since the rest of the mutations significantly affect DNA binding by NES, oligos 18-23 
were chosen for Table 3.1 because of the interesting differences in binding affinity for the 
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mutations within the DNA substrate. The mutations in the sequence at WT Thy21 to Ade21, 
Cyt21, and Gua21 and WT Ade20 to Thy20, Cyt20, and Gua20 were highlighted because their 
binding affinities did follow our initial thoughts that purine to purine substitutions would be 
better tolerated than purine to pyrimidine mutations. For example, one might expect that a 
mutation from Ade to Gua might be tolerated easier than a mutation from Cyt to Ade based on the 
structure of the purine and the pyrimidine bases. However, the Ki for the mutant substrates did 
not reflect this in all cases. Oligos 18-23 contain mutations in Ade20 and Thy21. These bases 
interact with four polar residues of NES and no contacts are made to the phosphate backbone 
(Figure 3.4). For oligo 18 we see that the binding affinity decreases ~4 fold due to the mutation. 
However, for oligo 19 there is a ~7 fold decrease in binding affinity. Figure 3.5.B,C help to 
explain this finding based on the structure. Even though the Thy21Ade mutation is a pyrimidine 
to a purine one can see from the structural analysis that in both cases the hydrogen bonds are 
disrupted. Figure 3.5.B shows the position of the Ade based on a model created from the 
difference maps. Ade21 is out of position to maintain both hydrogen bonds with R85 and N8 as 
seen in Figure 3.5.A. For Cyt21, Figure 3.5.C, it is clear that the structure of the base will allow 
for the base to be positioned in the same way as Thy21 but the primary amine on the cytosine is 
not a hydrogen acceptor resulting in a disrupted network. This would cause the base to not fit as 
well as Ade21 which is simply out of place. Oligo 20 had the most severe effect on the binding of 
the substrate of NES. Similarly to Ade21, Gua21 is out of position but also contains a primary 
amine that will have a steric clash with the loop that is above the base recognition site. From the 
binding data this clash has the most significant effect on the enzymes ability to bind to the 
substrate.  
 Oligos 21-23 represent mutations made to Ade20 that also had interesting binding 
affinities. Figure 3.6 compares the WT base position from the structure to the modeled mutations. 
Thy20 and Cyt20 have dissociation constants that are ~5 fold weaker than for the native substrate. 
It is clear from 3.6.B,C that the structure of the pyrimidine base is not sufficient for them to 
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maintain the hydrogen bond network between Y156 and Q82. For the mutant Gua20, which again 
had the most significant effect on binding, the structure would allow for the base to placed in the 
same position but the chemical composition does not allow for the maintenance of the WT 
hydrogen bond network as seen in Figure 3.6.A. Taken together, these data demonstrate that the 
bases recognized by NES on the single stretch of DNA, 3’ of the hairpin, have specific 
interactions and mutations from purine to pyrimidine as well as pyrimidine to pyrimidine have 
significant effects on the binding affinity.  
 The next set of oligos involves mutations made to the hairpin structure that change the 
specific base but maintain the secondary structure (Table 3.1, Oligos 24-29). The regions of NES 
primarily responsible for binding the hairpin portion of the DNA substrate have been termed 
Hairpin Loop1 (HL1) and Hairpin Loop2 (HL2). The residues present on these loops primarily 
have interactions with the deoxyribose-phosphate backbone of the DNA, but there are a few base 
specific hydrogen bonds as well. Figure 3.7 highlights the interactions made between these two 
loops and the DNA bases that were mutated in oligos 24-29. The interactions are a combination 
of side chain and main chain hydrogen bonds that form a clamp from either side of the DNA. The 
interesting observations made when analyzing the data were that mutations in Cyt17 did not 
significantly affect substrate binding where mutations in the next base, Gua18, severely decreased 
the enzymes ability to bind the DNA.  
 For oligos 24-26 the WT Gua18 and Cyt4 were mutated and the dissociation constants 
were calculated. Mutations to this base resulted in affinities that were ~10 – 215 fold weaker than 
the WT interaction. Figure 3.8.A focuses on the interaction with Gua18 and highlights the 
hydrogen bonds made through the side chain of R151 with the guanine base as well as the 
hydrogen bonds with the phosphate made from the side chain of K150 and the main chain 
interactions with S81 and Q82. As previously, the mutant bases were modeled into the density 
maps for comparison. This time the two largest effects come from mutating a purine to a 
pyrimidine. Both the Cyt18 and Thy18 mutations (oligos 24,25) position the base too close to 
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R151 resulting in a steric clash. This would either push the DNA base out of the binding pocket 
or require R151 and HL2 to move out of the space altering the hydrogen bond network for the 
other bases in the substrate. The Ade18 mutation does not result in a steric clash but it does 
disrupt the hydrogen bond with R151 by replacing the carbonyl group from guanine with a 
primary amine resulting in a ~10 decrease in binding affinity.  
 Structural analysis of the Cyt17 mutation provided an explanation for the lack of effect 
that mutations had on this position. Figure 3.9.A depicts the interactions made with HL1 and HL2 
with the WT Cyt17 base. Cyt17 hydrogen bond network primarily consists of interactions made 
with the phosphate backbone and the deoxyribose moiety. G153 does make a base specific 
interaction with Cyt17, but the majority of the recognition comes from the 6 backbone 
interactions. The mutation in oligo 27 has the largest effect due to the fact that the carbonyl group 
on guanine will require some movement by G153 to fit the base in the enzyme clamp (Figure 
3.9.B). The mutation in oligo 28 only results in the loss of the hydrogen bond with G153, thus the 
binding remains at WT levels. Mutating to Ade18 in oligo 29 again results in the loss of the bond 
with G153 and may have subtle effects on the hydrogen bond network due to the size difference 
(Figure 3.9.D) that leads to a decrease in binding affinity.  
3.4 Divalent Cation Analysis and DNA Cleavage Data Introduction 
 Once the relaxase has bound the oriT it must then catalyze the transesterification reaction. 
This reaction occurs at a specific nic site on the DNA that is aligned in the active site so that 
scissile phosphate can be attacked by the catalytic tyrosine 6,12,13. For the reaction to proceed the 
negatively charged phosphate must act as an electrophile. The HUH(+H) motif coordinates a 
divalent cation that is positioned next to the scissile phosphate. This positive charge on the cation 
will serve to neutralize the negatively charged phosphate, allowing to act as an electrophile 6,12,14-
16. The third requirement for successful cleavage is that the tyrosine must act as a nucleophile 
(Figure 1.5). At physiological pH the tyrosine hydroxyl is protonated because the pKa of tyrosine 
is 10. Deprotonation of the hydroxyl results from a neighboring residue or solvent molecule 
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acting as a base. Another possibility is that the local pH of the active site is higher than 
physiological pH (7-7.5).  
 The structure of NES 220 in complex with DNA reveals that in the active site is arranged 
in the typical fashion. In our structure, the HUH(+H) motif was seen to be coordinating a Ni2+ 
metal in the active site. The Y25F residue was positioned on α1 in a manner that it could be 
directed to attack the scissile phosphate (Figure 2.1). Unfortunately, our structure had a 
crystallographic defect that pulled the DNA out of the active site (Figure 2.4). However, it can 
easily be imagined that the DNA would lie on top of the active site and proceed along α1 and 
finally between α3 and the β2,3 loop (Figure 2.1). Similarly to the relaxase MobA of plasmid 
R1162, it is not possible to find an amino acid that is acting like a base to abstract the hydrogen 
from the carboxyl on Y25 17. We hypothesize that an ordered water molecule is acting as a 
specific base to accomplish this goal (Figure 1.5).  
 In the following sections we will outline the assays and the approach used to identify the 
true nic site for NES. We also examine the metal preference for the enzyme in vivo and determine 
the enzyme activity towards the substrate when in complex with each divalent cation. Following 
those experiments the effects of mutations on NES 220, determined from structural analysis, are 
also presented and discussed. Finally, we will propose a new strategy for inhibiting relaxases 
through the use of minor groove binding compounds such as the Hoechst 33528 stain.  
3.4.1 Methodology 
 Electrophoretic Mobility Shift Assays (EMSA). To determine what the true nic site in the 
oriT sequence was we used EMSA assays to visualize the equilibrium products of the cleavage 
reaction. Commercially synthesized oriT DNA substrates (IDT) were ordered with 5’ 6-FAM 
fluorescein molecules attached. Each oligo was resuspended and annealed as detailed in section 
3.2 and the sequences used are listed in Table 3.2.  
 Each reaction contained 8 µL of EMSA buffer (50 mM NaCl, 20 mM Tris pH 7.4, 0.02% 
v/v sodium azide), 1 µL of 50 µM NES 220 in sizing buffer, and 1 µL of 10 µM 5’ 6-FAM 
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labeled DNA substrate. The reaction was incubated at 37° C for 1 hr and quenched with the 
addition of 10 µL 2X quenching solution (0.01% xylene cyanol, 85% formamide, 20 mM EDTA, 
2X TAE, 0.2% SDS). The 20 µL were run through a denaturing 16% polyacrylamide gel (40 mL 
16% acrylamide gel stock (8M urea, 16% polyacrylamide/bisacrylamide, 1X TBE), 400 µL 10% 
ammonium persulfate (APS), 40 µL tetramethylethylenediamine (TEMED)) in 1X TBE running 
buffer to separate the substrate and products. The fluorescent oligos were visualized using a 
VersaDoc Imaging System, 4400 MP (BioRad) and the accompanying Quantity One software 
(BioRad). Band intensities were quantified using ImageJ 1.42 (Rasband, W.S., NIH 2008). Prior 
to quantification, standard background subtraction was performed on all gels. NES 220 was 
determined to be active the smaller product band was present in the gel. Activity was reported as 
a percent of the product band intensity divided by the product plus substrate intensities.  
 For the metal studies it was necessary to remove the natively bound metal through 
incubation of NES 220 in 500 µM EDTA overnight at 4° C. The metals of interested were then 
added in 10, 100, 1000 µM excess and activity was measured. The reaction conditions for the 
metal studies contained 7 µL of EMSA buffer (50 mM NaCl, 20 mM Tris pH 7.4, 0.02% v/v 
sodium azide), 1 µL of 50 µM NES 220 in sizing buffer incubated in 500 µM EDTA, 1 µL of 10 
µM 5’ 6-FAM labeled DNA substrate, and 1 µL of the metal in EMSA buffer at 10X the desired 
fold excess. The reaction was incubated at 37° C for 1 hr and quenched with the addition of 10 µL 
2X quenching solution (0.01% xylene cyanol, 85% formamide, 20 mM EDTA, 2X TAE, 0.2% 
SDS). Gels were run in the same fashion as for the nic site studies.  
 Inductively Coupled Plasma Mass Spectrometry (ICP-MS). NES 220 and NES 220 
H131A were analyzed by ICP-MS to determine the identity and concentration of metals present 
in the samples. Data were collected by the UNC-CH Chemistry Department Mass Spectrometry 
Core Facility on a Varian 820-MS (Palo Alto, CA). Protein was first digested for 4 hrs. in 70% 
nitric acid (HNO3). Each sample was then diluted in 5.5 ml of 1.4% HNO3. Data were collected 
as part per billion (ppb) and converted to µM. The original concentration of each metal in each 
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sample was then determined in Excel 2007 (Microsoft, 2011). Data were then presented as 
percent bound of the total concentration of protein.  
3.4.2 DNA Cleavage, Metal Preference, and Mutant Analysis 
 The other relaxases studied to date ( TraI F, TrwC R388, MobA R1162, and TraI pCU1) 
have been active against the DNA substrate in a metal dependent manner but the optimal metal is 
still under debate 12,13,16,18,19. We set about to determine if NES 220 was able to cleave the product, 
the exact position of the nic site, and which metals allowed activity in vitro. To determine if NES 
was active against the oriT substrate oligo 1 in Table 3.2 was used. This oligo contained the 
hairpin, single stretch of DNA, and 8 DNA bases 3’ of the nic site. The intial experiment was run 
in EMSA buffer with the DNA probe and NES. A ladder was made that consisted of the original 
substrate and a shorter probe that was designed to be the same length as the cleaved product 
(Table 3.2 – oligos 1,2; Figure 3.10). Controls were also run that contained NES incubated in 500 
µM EDTA overnight, incubated NES plus Ni2+, and a mutant form of NES that disrupted the 
metal binding motif NES H131A. The initial results in Figure 3.11.A were surprising because the 
product of the reaction did not have the correct predicted length based on previous alignment 
studies of NES from pGO1 20. However, we were able to determine that incubation with EDTA 
will inhibit activity, addition of a divalent cation will regain function, NES H131A disrupts the 
HUH motif and inhibits function (Figure 3.11.A), and NES Y25F is not capable of cleavage. In 
order to determine the exact nic site truncation oligos were ordered (Table 3.1, oligos 3,4) and 
used in the assay. Oligo 4 corresponded to the correct length for the products observed (Figure 
3.11.B). This allowed us to determine that the true nic site for NES 220 of pLW1043 was 
between Gua28 and Cyt29. This finding also corroborated our DNA binding data in Table 3.1 
because the affinity was improved by the presence of the true nic site in oligos 2,3, and 13.  
 Now that we had established to the true site at which the DNA was cleaved and that our 
assay was functional we wanted to investigate the enzyme’s preference for different metals. To 
accomplish this goal NES 220 was incubated with EDTA to remove all bound metals. We chose 
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to investigate the effects of NiCl2, MgCl2, MnCl2, CaCl2, ZnCl2, FeCl2, CoCl2, and CuCl2 by 
adding them in 10 µM, 100 µM, or 1000 µM excess to the concentration of EDTA in the NES 
stocks. When NES 220 was incubated with the substrate and a natively bound metal it cleaved 
~16% of the substrate with some variability (Figure 3.12). The metals that were able to support 
the cleavage reaction were Ni2+, Mn2+, Co2+, and Cu2+ as seen in Figure 3.12. Mn2+ was the only 
metal that showed an increase in activity in a concentration dependent manner. However, Ni2+ 
had the most consistent activity at the concentrations tested. The ICP-MS data presented in Table 
3.3 leads us to believe that NES is coordinating a nickel ion due to the purification method. When 
the NES H131A sample was analyzed no metals were found to be present in significant 
concentrations. Since Ni2+ concentrations in the cell cytoplasm are very low 21,22, we believe the 
presence of nickel does not indicate its use in vivo. Furthermore, Mn2+ was able to support 
cleavage (Figure 3.12), which correlates with what was seen in MobA 19, the most similar enzyme 
to NES. Co2+ and Cu2+ were able to support cleavage in NES but showed a decrease in activity at 
higher concentrations.  Co2+ and Cu2+ are not used prevalently in biological systems and we 
conclude that these metals are most likely not used in vivo. From these data we believe NES most 
likely uses Mn2+ in vivo to help position the DNA into the active site and achieve cleavage of the 
DNA substrate.  
 Next we were curious to understand the effects of mutating some of the key bases 
identified in the previous section by observing their effect on the cleavage equilibrium. To do this 
oligos 5-10 from Table 3.2 were used in the EMSA assay. Oligo 5 contains mutations that will 
disrupt the hairpin. Oligos 6 and 7 contain mutations in Ade20 and Thy21. Oligos 8 and 9 contain 
mutations in the two hairpin bases discussed previously. Lastly, oligo 10 contains an abasic site at 
position Gua26. In Figure 3.13.A the percent of the fluorescent product formed in all cases was 
higher than WT substrate. For oligos 5-8 this was most likely due to the disruption in the ability 
of the enzyme to bind the DNA. The amounts of DNA seen in the EMSA assay represent the 
equilibrium that is in place between the cleavage and ligation activities of NES. For WT in 
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3.13.A this means that 19% of the shorter product is either free in solution or bound to NES. 
Oligos 5-8 have a lower affinity for NES and this will actually drive the equilibrium to produce 
more of the shorter product. This is due to the fact that once the enzyme cleaves the DNA 
substrate the remaining piece must be held in the enzyme in the correct position to allow for 
religation. Since the enzyme is not able to bind these mutants as well (Table 3.1) it will have a 
hard time maintaining the proper positioning, thus driving the equilibrium to contain more 
truncated product. Oligo 9 was interesting because it did not show a decrease in binding affinity 
but still had increased product formation. This could be due to the fact that even though the 
enzyme can bind the DNA, the optimal contacts are not present and still results in a shift of the 
equilibrium. An abasic site was inserted into oligo 10 to better understand the role of Gua26. In 
the structure this base appears to act as a post helping to aid the DNA in forming the U-turn into 
the active site (Figure 3.3). When the abasic site oligo was used in the EMSA assay the 
equilibrium was shifted even further towards product formation to ~60%. One can imagine that a 
loss of the base at position Gua26 would result in Cyt27 and Gua28 moving away from the active 
site. This is because there is only one interaction, phosphate backbone of Cyt27 with N129, for 
the six bases on the single strand of DNA. This would most likely result in large movements of 
these bases making it difficult to successfully perform the religation reaction because the 3’ base 
of the nic site will not be in the proper position to attack the tyrosine phosphate bond.  
 Mutant forms of NES were purified as previously described. We wanted to investigate 
the effects of mutations near the active site of the enzyme to shed more light on the catalytic 
mechanism. In figure 3.14 K22, E86, and Y42 were mutated to alanine. This was to determine 
side chains of the residues were playing a role in the active site chemistry. A21 was mutated to a 
glutamic acid to see if a bulky residue would affect cleavage by disrupting the binding with the 3’ 
side of the nic site.  The results of the EMSA assays for these mutant enzymes are shown in 
Figure 3.13.B. The K22A mutation resulted in a ~1.5 fold increase in activity where the E86A 
mutation results in a ~3 fold decrease in activity. This result indicates that K22 is most likely not 
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playing a role in the catalytic mechanism and removal of this side chain may allow another water 
molecule to be ordered in the hydrogen bond network required to activate the carbonyl group on 
Y25. Furthermore, this provides evidence that E86 is involved in the reaction and most likely 
orders a water molecule to act as a specific base to allow the hydrogen abstraction (Figure 3.14). 
The Y42A mutation resulted in a loss of activity. This residue is found on a loop between β3 - β4 
and may have enough mobility to position itself to act as a secondary catalytic tyrosine as seen in 
pCU1 and TrwC 23,24. However, this is most likely not the case as the Y25F mutation in NES 
results in no cleavage product (Figure 3.11.A) leading to the assumption that no other residue can 
act like a nucleophile in this system. This would indicate that Y42 is most likely playing a role to 
bind and position the DNA 3’ of the nic site. The A21E mutation was selected to determine if 
placing a larger residue in the groove where we believe the DNA 3’ of the nic must be positioned 
by the enzyme. Similarly to Y42A, this mutation resulted in a decrease of activity. This results 
seems to implicate both Y42 and A21 as being in areas that are responsible for binding to the 
single portion of the DNA 3’ of the nic site. The final mutant enzyme tested was the HL2 loop 
deletion. This loop was removed through site directed mutagenesis and purified in the same as 
previously described. The HL2 deletion enzyme was able to cleave the substrate DNA and 
resulted in the most drastic increase in activity. Again, this is due to favoring the product side of 
the equilibrium for the reaction. Given that these residues are so critical in recognizing and 
binding the hairpin the increased cleavage must be do to the fact that the enzyme will have 
random interactions with the DNA. On the chance that the substrate enters the active site properly 
and is cleaved, there is no hope of the enzyme maintaining the proper contacts with the hairpin 
portion of the substrate to allow for religation.  
 Using the information gained from the biochemical analysis we sought out to investigate 
novel methods to inhibit NES. The data clearly show that a few DNA bases are extremely 
important and extensive interactions are made with the DNA through HL1 and HL2. We sought 
to go a different route than inhibiting the active site as for F TraI 18 because this route proved to 
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be non-specific. The hairpin is long enough to form a small minor groove and it is located directly 
between HL1 and HL2. We sought out molecules that could bind in the minor groove and wanted 
to test the effect of these molecules. The first two compounds tried, berberine and netropsin, did 
not show an effect for DNA cleavage (data not shown). We next tried Hoechst 33258 (Figure 
3.15.A) and found some interesting results. To test the effects of this molecule we incubated 20X 
DNA stocks with ~ 47, 23, and 12 fold excess of Hoechst. Figure 3.15.B shows that 47 fold 
excess of Hoechst was able to inhibit the enzymes function in vitro. The large excess is required 
due to the fact that the minor groove is short and does not contain many Ade or Thy which 
Hoechst prefers to bind to. Further work will need to be done to confirm the exact reason for the 
inhibition and to develop novel more specific inhibitors. However, this strategy provides hope to 
that it may be possible to create novel inhibitors towards the relaxase through disrupting an area 
of functional importance on the protein other than active site.  
3.5 Conclusions 
 From the structural analysis combined with the biochemical we have been able to 
understand how the relaxase domain of NES is able to bind the DNA and cleave at the 
appropriate position. The direct binding studies revealed that NES 220 has an 18.24 nM KD for 
the oriT DNA substrate. Furthermore we determined that for successful binding the hairpin 
secondary structure in the DNA must be present. The competition assays corroborated the 
structural evidence that key DNA bases are responsible for the highly sequence specific 
interaction. The hairpin has multiple bases and backbone interactions that allow the complex to 
maintain the correct orientation while there are few interactions along the single strand stretch of 
DNA leading up to the nic site.  We were able to determine that one critical base along this 
stretch, Gua26, has multiple interactions with the enzyme and is required for the proper alignment 
of the nic site in the DNA. Deletion of this base drives the reaction equilibrium to product 
formation highlighting its critical role in position the substrate. Through the EMSA cleavage 
assays we were able to determine the true nic site between Gua28 and Cyt29 on the oriT sequence. 
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Metal assays revealed that Ni2+, Mn2+, Co2+, and Cu2+ were able to facilitate the cleavage reaction. 
We determined that Mn2+ was most like the metal used in vivo based on these findings and the 
fact that the other biologically relevant metals, Mg2+, Ca2+, and Zn2+ showed no activity in our 
cleavage assay. Through using mutant DNA oligos to investigate cleavage we determined that 
efficient binding is necessary for proper religation of the substrate. This was due to the fact that 
mutant oligos that decreased the binding affinity resulted in greater product formation. When the 
active site of the enzyme was probed through structural mutations we were able to learn more 
about the catalytic mechanism employed by NES. Specifically, we determined that E86 is 
involved in the hydrogen bond network that allows for the deprotonating of the tyrosine carboxyl 
group.  Mutations, Y42A and A21E, in the part of the enzyme that interact with the DNA 
substrate 3’ of the nic site reduced activity. From this result we conclude that this region of the 
enzyme is responsible for maintaining the correct position of the DNA during the cleavage 
reaction. Finally, we used this information to aid us in a novel approach to inhibit relaxase 
enzymes. Through the use of a minor-groove binding molecule, Hoechst 33258, we were 
successful in halting the cleavage reactions. These data provide novel insights into how NES 
functions to allow successful CPT and a unique strategy to inhibit this vital process in bacteria. 
Through these experiments we hope to develop novel and specific compounds that can be used as 
antibiotics to help fight the spread of antibiotic resistance.  
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 5’                                  Oligonucleotides                                    3’   
 Direct Binding KD(nM) R2 
1 6FAM-CACGCGAACGGAACGTTCGCATAAGTGCGCC 18.24 ± 2.71 0.97 
 Competition Binding Ki R2 
2 GCACGCGAACGGAACGTTCGCATAAGTGCG 313.0 0.99 
3 CACGCGAACGGAACGTTCGCATAAGTGCGC 14.8 0.99 
4 ACGCGAACGGAACGTTCGCATAAGTGCGCC 8.1 0.99 
5 CGCGAACGGAACGTTCGCATAAGTGCGCCC 9.2 0.99 
6 GCGAACGGAACGTTCGCATAAGTGCGCCCT 4.0 0.99 
7 CGAACGGAACGTTCGCATAAGTGCGCCCTT 14.2 0.99 
8 GAACGGAACGTTCGCATAAGTGCGCCCTTA 16.8 0.99 
9 AACGGAACGTTCGCATAAGTGCGCCCTTAC 1,990.1 0.99 
 Truncation Competition Ki(nM) R2 
10 GAACGGAACGTTCGCATAAGTGCGCCC 1,085.8 0.99 
11         CGGAACGTTCGCATAAGTGCGCCC 940,533.4 0.99 
12              GAACGTTCGCATAAGTGCGCCC N.B.  
13 CGCGAACGGAACGTTCGCATAAGTGCG 6.0 0.99 
14                CGCGAACGGAACGTTCGCATAAGT 97.5 0.99 
15                CGCGAACGGAACGTTCGCATA 838.0 0.99 
16                CGCGAACGGAACGTTCGC N.B.  
 Mutation Competition Ki  
17 ACCTATCGTGAACGTTCGCATAAGTGCGC 564.6 nM 0.99 
18 ACGCGAACGGAACGTTCGCAAAAGTGCGCC 86.6 nM 0.99 
19 ACGCGAACGGAACGTTCGCACAAGTGCGCC 139.2 nM 0.99 
20 ACGCGAACGGAACGTTCGCAGAAGTGCGCC 531.4 nM 0.99 
21 ACGCGAACGGAACGTTCGCTTAAGTGCGCC 80.3 nM 0.99 
22 ACGCGAACGGAACGTTCGCCTAAGTGCGCC 97.9 nM 0.99 
23 ACGCGAACGGAACGTTCGCGTAAGTGCGCC 448.5 nM 0.99 
24 ACGGGAACGGAACGTTCCCATAAGTGCGCC 4.28 µM 0.99 
25 ACGAGAACGGAACGTTCTCATAAGTGCGCC 1.93 µM 0.99 
26 ACGTGAACGGAACGTTCACATAAGTGCGCC 0.21 µM 0.99 
27 ACGCCAACGGAACGTTGGCATAAGTGCGCC 0.29 µM 0.99 
28 ACGCAAACGGAACGTTTGCATAAGTGCGCC 0.02 µM 0.99 
29 ACGCTAACGGAACGTTAGCATAAGTGCGCC 0.09 µM 0.99 
30 ACGCGAACGCGAATCCGTTCGCATAAGTGCGCC 0.04 µM 0.99 
Table 3.1 DNA Competition Oligonucleotides and Binding Affinities 
 
This is a representative list of the DNA oligonucleotides used in the binding experiments. A 
zigzag underline corresponds to the bases involved in forming the hairpin. For oligos 1-13 bold 
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bases correspond to the true nic site where italicized bases represent the hypothesized nic site. 
Bold bases are mutations made to the WT sequence for oligos 17-30. N.B. stands for no binding 
observed.  
 
 
 
 
 
 
 
 
 
 
 
 5’                            EMSA DNA Oligo Substrate Sequences                             3’ 
1 6FAM-ACGCGAACGGAACGTTCGCATAAGTGCGCCCCTTACGG 
2        6FAM-ACGCGAACGGAACGTTCGCATAAGTGCGCC 
3        6FAM-ACGCGAACGGAACGTTCGCATAAGTGCGC 
4        6FAM-ACGCGAACGGAACGTTCGCATAAGTGCG 
5 6FAM-ACCTATCGTGAACGTTCGCATAAGTGCGCCCCTTACGG 
6 6FAM-ACGCGAACGGAACGTTCGCAGAAGTGCGCCCCTTACGG 
7 6FAM-ACGCGAACGGAACGTTCGCGTAAGTGCGCCCCTTACGG 
8 6FAM-ACGGGAACGGAACGTTCCCATAAGTGCGCCCCTTACGG 
9 6FAM-ACGCAAACGGAACGTTTGCATAAGTGCGCCCCTTACGG 
10 6FAM-ACGCGAACGGAACGTTCGCATAAGT   CGCCCCTTACGG 
Table 3.2 DNA EMSA Oligonucleotides 
Labeled fluorescent DNA oligonucleotids used in the EMSA cleavage assays. A zigzag underline 
corresponds to the DNA hairpin. Italicized bases represent hypothesized nic site. Bold bases 
represent the true nic site. Bold and italicized bases represent mutations made to the WT sequence.  
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 NES 220 Y25F NES 220 Y25F, H131A 
Ni 20.68 % 0.16% 
Mg 0.75 % 1.40 % 
Mn 0.00 % 0.01 % 
Ca 0.24% 0.44 % 
Zn 2.85 % 0.11 % 
Fe 0.32 % 0.39 % 
Table 3.3 ICP-MS Results 
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Figure 3.1 NES Relaxase Direct Binding to DNA Substrate 
 
Fluorescence anisotropy experiments examining the binding affinity of NES for the oriT and 
control oligos. A. Binding data from 5 experiments run in triplicate. NES 220 has a Kd of 
18.24 nM for the oriT. B. Control experiment with a random sequence DNA oligo of the 
same length. No specific binding was observed. C. Control experiment with a random 
sequence of DNA that maintains the hairpin secondary structure. No specific binding was 
observed.  
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Figure 3.2 Representative DNA Competition Experiment Data 
 
A. An example of a competitor oligo that cannot compete with the reference substrate when 
encountered by NES. B. An example of a competitor oligo that can compete with the 
reference substrate when encountered by NES. All experiments were run in triplicate and 
standard error is graphed for each concentration.  
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Figure 3.3 Guanine 26 Interaction with NES 
 
The hydrogen bond network between residues in NES and Gua26. Gua26 acts like a post 
holding the DNA in the correct position cleavage and religation reactions. The N-terminal A2 
and N129 make side chain interactions with the DNA base. P130 and L91,N93 (not labeled) 
make main chain interactions with the Gua26 base.   
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Figure 3.4 NES Residue Interactions with Ade20 and Thy21 of the Single Strand 
 
Q82 and Y156 form hydrogen bonds with base of Ade20. N8 and R85 hydrogen bond with 
the carbonyl group on Thy21. The base specific interactions along the single stranded portion 
of the substrate allow for NES to bind in a sequence specific manner.  
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Figure 3.5 Structural Evidence for the Binding Effects of Thy21 Mutants  
 
A. Diagram from the crystal structure showing R85 and N8 hydrogen bonding with the 
carbonyl group of Thy21. B. Diagram of Ade21 modeled into the difference density map. 
The binding affinity for this mutant can be found in Table 3.1, oligo 18. C. Diagram of Cyt21 
modeled into the difference density map. The binding affinity for this mutant can be found in 
Table 3.1, oligo 19. D. Diagram of Gua21 modeled into the difference density map. The 
binding affinity for this mutant can be found in Table 3.1, oligo 20.  
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Figure 3.6 Structural Evidence for the Binding Effects of Ade20 Mutants  
 
A. Diagram from the crystal structure showing Q82 and Y156 hydrogen bonding with the 
amines of Ade20. B. Diagram of Thy20 modeled into the difference density map. The 
binding affinity for this mutant can be found in Table 3.1, oligo 21. C. Diagram of Cyt20 
modeled into the difference density map. The binding affinity for this mutant can be found in 
Table 3.1, oligo 22. D. Diagram of Gua20 modeled into the difference density map. The 
binding affinity for this mutant can be found in Table 3.1, oligo 23.  
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Figure 3.7 NES Binding Site for the Hairpin on the DNA Substrate 
 
The hairpin is recognized by two loops in NES that for a clamp to hold the DNA substrate in 
place during CPT. Two base pairs are shown and the hydrogen bonds between Hairpin 
Loop1, Hairpin Loop2, and the DNA are shown in black.  
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Figure 3.8 Structural Evidence for the Binding Effects of Gua18 Mutants  
 
A. Diagram from the crystal structure showing R151 hydrogen bonding with the Gua18 base. 
S81, Q82, and K150 have interactions with phosphate backbone.  B. Diagram of Cyt18 
modeled into the difference density map. The binding affinity for this mutant can be found in 
Table 3.1, oligo 24. C. Diagram of Thy18 modeled into the difference density map. The 
binding affinity for this mutant can be found in Table 3.1, oligo 25. D. Diagram of Ade18 
modeled into the difference density map. The binding affinity for this mutant can be found in 
Table 3.1, oligo 26.  
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Figure 3.9 Structural Evidence for the Binding Effects of Cyt17 Mutants  
 
A. Diagram from the crystal structure showing G153 hydrogen bonding with the Cyt17 base. 
R78, R139, and K150 have interactions with phosphate backbone.  B. Diagram of Gua17 
modeled into the difference density map. The binding affinity for this mutant can be found in 
Table 3.1, oligo 27. C. Diagram of Thy17 modeled into the difference density map. The 
binding affinity for this mutant can be found in Table 3.1, oligo 28. D. Diagram of Ade17 
modeled into the difference density map. The binding affinity for this mutant can be found in 
Table 3.1, oligo 29.  
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Figure 3.10 Schematic of Cleavage Activity EMSA Assays 
 
The original DNA substrate with a 5’ 6-FAM fluorophore is shown in grey. The nic site is 
located at the red arrow. Once the substrate is combined with NES 220 and incubated, NES 
will cleave the substrate resulting in a shorter fluorescent oligo and ## base DNA is 
covalently attached to NES. To investigate the metal preference EDTA and specific divalent 
metals can be added to the assay to measure their activity. The ladder for the experiments 
contained the original 38 base probe, the shorter 28 base probe, and no enzyme.  
NES 220	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Figure 3.11 EMSA Assay and Controls  
 
A. Initial EMSA using the oriT probe and the hypothesize nic site to create the ladder. Lane 1 
shows NES is active but cutting at a different site. Lane 2 shows that EDTA can inhibit the 
activity of NES through chelating the metals. Lane 3 shows that adding in a divalent cation 
will reconstitute activity. Lane 4 shows that the Y25F mutation in NES is catalytically dead. 
B. New nic site is two bases shorter than previously reported for NES of pGO1. 
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Figure 3.12 Divalent Cation Analysis 
 
This figures depicts the activity of NES when giving various divalent cations in the EMSA 
experiments. Ni2+, Mn2+, Co2+, and Cu2+ showed activity that was comparable to WT. From 
these data we hypothesize NES uses Mn2+ in vivo due to its biological relevance and what 
has been seen in other systems.  
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Figure 3.13 Mutant DNA Oligo and Protein EMSA Assays 
 
A. Activity of NES when given mutant oligos as substrates. Each mutation drives the 
equilibrium towards product formation indicating that the enzyme is unable to efficiently 
bind to the truncated product. The oligos are from table 3.2. B. The activity of mutant forms 
of NES when given the WT substrate. All measurements were done in triplicate and S.E. is 
shown.  
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Figure 3.14 Mutations Made to the Active Site of NES 
 
A diagram of the active site of NES. Mutated residues are shown in magenta.  
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Figure 3.15 Hoechst 33258 Structure and Inhibition EMSA 
 
A. Structure of Hoechst 33258. B. EMSA experiment after incubating the DNA substrate 
with Hoechst 33258.  
 
NH+
N
H3C
H+
N
N
H
N
H+
NH
OH
A 
B 
 78 
3.7 References 
 
1. Pansegrau, W. & Lanka, E. Mechanisms of initiation and termination reactions in conjugative 
DNA processing. Independence of tight substrate binding and catalytic activity of relaxase (TraI) 
of IncPalpha plasmid RP4. J Biol Chem 271, 13068-13076 (1996). 
 
2. de la Cruz, F., Frost, L. S., Meyer, R. J. & Zechner, E. L. Conjugative DNA metabolism in 
Gram-negative bacteria. FEMS Microbiol Rev 34, 18-40. 
 
3. Nash, R. P., Habibi, S., Cheng, Y., Lujan, S. A. & Redinbo, M. R. The mechanism and control 
of DNA transfer by the conjugative relaxase of resistance plasmid pCU1. Nucleic Acids Res 38, 
5929-5943, doi:10.1093/nar/gkq303 (2010). 
 
4. Morton, T. M., Eaton, D. M., Johnston, J. L. & Archer, G. L. DNA sequence and units of 
transcription of the conjugative transfer gene complex (trs) of Staphylococcus aureus plasmid 
pGO1. J Bacteriol 175, 4436-4447 (1993). 
 
5. Berg, T. et al. Complete nucleotide sequence of pSK41: evolution of staphylococcal 
conjugative multiresistance plasmids. J Bacteriol 180, 4350-4359 (1998). 
 
6. Guasch, A. et al. Recognition and processing of the origin of transfer DNA by conjugative 
relaxase TrwC. Nat Struct Biol 10, 1002-1010, doi:10.1038/nsb1017 (2003). 
 
7. Stern, J. C. & Schildbach, J. F. DNA recognition by F factor TraI36: highly sequence-specific 
binding of single-stranded DNA. Biochemistry 40, 11586-11595 (2001). 
 
8. Williams, S. L. & Schildbach, J. F. Examination of an inverted repeat within the F factor origin 
of transfer: context dependence of F TraI relaxase DNA specificity. Nucleic Acids Res 34, 426-
435, doi:10.1093/nar/gkj444 (2006). 
 
9. Nikolovska-Coleska, Z. et al. Development and optimization of a binding assay for the XIAP 
BIR3 domain using fluorescence polarization. Anal Biochem 332, 261-273, 
doi:10.1016/j.ab.2004.05.055 (2004). 
 
10. Nikolovska-Coleska, Z. et al. Design and characterization of bivalent Smac-based peptides as 
antagonists of XIAP and development and validation of a fluorescence polarization assay for 
XIAP containing both BIR2 and BIR3 domains. Anal Biochem 374, 87-98, 
doi:10.1016/j.ab.2007.10.032 (2008). 
 
11. Weigel, L. M. et al. Genetic analysis of a high-level vancomycin-resistant isolate of 
Staphylococcus aureus. Science 302, 1569-1571 (2003). 
 
12. Boer, R. et al. Unveiling the molecular mechanism of a conjugative relaxase: The structure of 
TrwC complexed with a 27-mer DNA comprising the recognition hairpin and the cleavage site. J 
Mol Biol 358, 857-869, doi:10.1016/j.jmb.2006.02.018 (2006). 
 
13. Larkin, C. et al. Inter- and intramolecular determinants of the specificity of single-stranded 
DNA binding and cleavage by the F factor relaxase. Structure 13, 1533-1544, 
doi:10.1016/j.str.2005.06.013 (2005). 
 79 
14. Ilyina, T. V. & Koonin, E. V. Conserved sequence motifs in the initiator proteins for rolling 
circle DNA replication encoded by diverse replicons from eubacteria, eucaryotes and 
archaebacteria. Nucleic Acids Res 20, 3279-3285 (1992). 
 
15. Koonin, E. V. & Ilyina, T. V. Computer-assisted dissection of rolling circle DNA replication. 
Biosystems 30, 241-268 (1993). 
 
16. Larkin, C., Haft, R. J., Harley, M. J., Traxler, B. & Schildbach, J. F. Roles of active site 
residues and the HUH motif of the F plasmid TraI relaxase. J Biol Chem 282, 33707-33713, 
doi:10.1074/jbc.M703210200 (2007). 
 
17. Monzingo, A. F., Ozburn, A., Xia, S., Meyer, R. J. & Robertus, J. D. The structure of the 
minimal relaxase domain of MobA at 2.1 A resolution. J Mol Biol 366, 165-178 (2007). 
 
18. Lujan, S. A., Guogas, L. M., Ragonese, H., Matson, S. W. & Redinbo, M. R. Disrupting 
antibiotic resistance propagation by inhibiting the conjugative DNA relaxase. Proc Natl Acad Sci 
U S A 104, 12282-12287 (2007). 
 
19. Xia, S. & Robertus, J. D. Effect of divalent ions on the minimal relaxase domain of MobA. 
Arch Biochem Biophys 488, 42-47, doi:10.1016/j.abb.2009.06.004 (2009). 
 
20. Climo, M. W., Sharma, V. K. & Archer, G. L. Identification and characterization of the origin 
of conjugative transfer (oriT) and a gene (nes) encoding a single-stranded endonuclease on the 
staphylococcal plasmid pGO1. J Bacteriol 178, 4975-4983 (1996). 
 
21. Finney, L. A. & O'Halloran, T. V. Transition metal speciation in the cell: insights from the 
chemistry of metal ion receptors. Science 300, 931-936, doi:10.1126/science.1085049 (2003). 
 
22. Harding, M. M. Geometry of metal-ligand interactions in proteins. Acta Crystallogr D Biol 
Crystallogr 57, 401-411 (2001). 
 
23. Grandoso, G. et al. Two active-site tyrosyl residues of protein TrwC act sequentially at the 
origin of transfer during plasmid R388 conjugation. J Mol Biol 295, 1163-1172, 
doi:10.1006/jmbi.1999.3425 (2000). 
 
24. Nash, R. P., Niblock, F. C. & Redinbo, M. R. Tyrosine partners coordinate DNA nicking by 
the Salmonella typhimurium plasmid pCU1 relaxase enzyme. FEBS Lett 585, 1216-1222, 
doi:10.1016/j.febslet.2011.03.043 (2011). 
Chapter 4 
 Structure of C-term Domain and SAXS Envelope 
4.1 Introduction 
 The N-terminal domain of NES contains the relaxase fold and is required for successful 
CPT of pLW1043. After studying the relaxase domain we were curious to investigate the role of 
the C-terminal residues 221_665. The relaxases from TrwC, F plasmid, and pCU1 all contain C-
terminal helicase domains while R1162 contains a primase 1-4. These domains play a role in 
processing the DNA during CPT. We assumed NES would have a similar domain organization to 
the other relaxases but were surprised when sequence alignments and structure predictions did not 
provide any significant matches. This left us wondering what the functional role of the ~400 
amino acids on the C-term of NES was. We set out to determine the structure of the C-terminal 
domain to in hopes of shedding light on this question. The experimental procedures and results 
are presented in the following sections.  
4.2 Construct and Oligonucleotide Design, Mutagenesis, Expression and Purification 
 The C-Terminal Domain of NES, NES 221-665, was cloned and purified as previously 
mentioned in Chapter 2. Briefly, all constructs in the following work were cloned and expressed 
into the CPD-Lasso expression vector using the NdeI (5’) and BamHI (3’) restriction 
endonuclease sites. Truncation constructs were made by adding stop codons through site directed 
mutagenesis and sequences were again confirmed by Eton Biosciences, Inc. The resultant cloned 
proteins were purified in the same fashion as used in crystallization trials. After HisTrap and size 
exclusion chromatography the pure fractions were combined, flash frozen in liquid nitrogen, and 
frozen in stocks stored at -80 °C for use in experiments. 
4.3 Limited Proteolysis and N-terminal Sequencing 
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 Limited proteolysis and N-terminal sequencing were used to determine the optimal start 
position for the C-term constructs. For the limited proteolysis trypsin and proteinase K were 
prepared in suitable buffers and diluted to a working concentration of 0.01 mg/mL. The trypsin 
buffer consisted of 20 mM CaCl and 1mM HCl at pH 7.5 and the proteinase K buffer consisted of 
5 mM CaCl and 10 mM NaCl at pH 7.5. The reaction buffer was 20 mM Tris pH 7.5 and 300 
mM NaCl. The reaction consisted of NES 665 (+DNA) at 0.6 mg/mL in 39 µL of reaction buffer. 
5 µL of this solution were removed for an initial time point. 1 µL of protease was added to the 
remaining 34 µL to initiate the reaction. 5 µL were removed at time points of 1, 5, 15, 30, 60, and 
120 minutes. The aliquots were added to tubes that contained 2 µL of 150 mM 
phenylmethanesulfonylfluoride (PMSF) and 3 µL of 5x laemelli loading dye. Following the 
quench the samples were boiled for 2 minutes to prepare for sodium dodecyl sulfate 
polyacrylamide gel (SDS-PAGE) electrophoresis.  
 The limited proteolysis with both trypsin and proteinase K resulted in the formation of a 
distinct band that corresponded to a MW of ~50 kDa (Figure 4.1). In both cases the addition of 
the oriT DNA did not seem to affect the protease activity. Given the relaxase domain of NES has 
a MW of ~26 kDa and the full-length protein has a MW of ~79 kDa we hypothesized that this 
fragment represented to the C-terminal domain of NES. The next step was to determine the N-
terminal sequence of this fragment to confirm our hypothesis. 
 To determine this sequence we sent samples to the W.M. Keck Sequencing Facility at 
Yale University for analysis. Edman sequencing was carried out on an Applied Biosystems 
protein sequencer equipped with an on-line HPLC system. The samples purified by SDS-PAGE 
were electroblotted onto polyvinylidene fluoride (PVDF) membrane. PVDF bands were stained 
with Coomassie Blue and destained extensively with 4 changes of destaining solvent, and washed 
with 3-4 changes of ultra-pure water to lower the very high concentrations of Tris, glycine, and 
other gel and transfer buffers that otherwise will interfere with sequencing. After air drying, the 
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bands or spots of interest were individually excised and placed in 1.5 ml Eppendorf tubes for 
shipment to the Keck Facility. Figure 4.2 shows the data generated from the Keck facility for the 
samples provided. The sequence was compared to NES 665 sequence to identify any residues that 
were in the same order. We were in fact able to find this sequence and the first base was K228. 
The molecular weight of NES 228_665 is ~52 kDa, which corresponded well with our data form 
the limited proteolysis. This portion of the protein sequence was analyzed using the Phyre server 5 
to determine if the sequence or the structure was similar to any known enzymes. Unfortunately, 
from this analysis were not able to find any homologues that had previously been studied leaving 
us with questions about the function of the C-terminal domain of NES. Using the secondary 
structure predictions generated from the server, we were able to design multiple truncation 
constructs by removing C-terminal portions at predicted loop regions. 11 constructs were 
designed that incorporated these truncations into the C-terminal domain and full-length protein 
(Figure 4.3) 
4.4 Circular Dichroism and Dynamic Light Scattering of NES C-term 
 Circular dichroism (CD) and dynamic light scattering (DLS) were used in conjunction to 
investigate the size distribution profile and secondary structure of the C-terminal domain. CD 
measurements were made on a Chirascan CD Spectrometer (AppliedPhotophysics) with the 
protein (NES 228_594) diluted into CD buffer (200 mM KF, 10 mM potasim phosphate buffer 
pH 7.4) to a concentration of 5 uM. A wavelength scan from 190-260 nm revealed a protein that 
was folded containing α-Helices. This was determined by the presence of a positive peak at 190 
nm and a double negative peak at 208 and 225 nm (Figure 4.4.A). The resulting ensemble of 
peaks made us believe that the protein was in fact folded and primarily α-Helical in nature which 
was in agreement with the secondary structure predictions. Thermal denaturation was performed 
while monitoring the 208 nm and 222 nm wavelengths that corresponded to the two negative 
peaks from the α-Helix signal. The melting temperature (Tm) was determined to be approximately 
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33 °C by observing where half to the protein was in a folded versus unfolded state from the data 
(Figure 4.4.B). This low Tm is characteristic of a protein that is not very stable.  
 Dynamic light scattering was performed on a Dynapro Dynamic Light Scattering Plate 
Reader (Wyatt Technology Corp.). Prior to measurement the samples were spun at 13,000 xg to 
ensure no dust or sediments would affect the measurement. The sample of NES 228_594 was 
measured at 10 mg/mL and showed the presence of multiple species.  The major peak had a 
polydispersity of 17.6% and a radius of hydration of 5.4 nm (Figure 4.5). The molecular weight 
calculated from this reading was 172 kDa, corresponding to roughly a trimer or a molecule that is 
not spherical in shape. The other two peaks represented only 1% of the signal. Taken together 
these data are representative of a well folded, but unstable and in multiple states. CD and DLS 
measurements were taken on the other C-terminal constructs that incorporated both C-terminal 
and N-terminal truncations. All of the samples tested had a low Tm had similar size profile 
characteristics (data not shown).  
4.5 Crystallization, Data Collection, and Data Processing 
 Selenomethionine-substituted protein was used in crystal trials to obtain phase 
information upon data collection. NES 243_594 (10 mg/mL) was crystallized in a solution 
containing 16% PEG 4,000, 5% PEG 400, 500 mM lithium chloride, 100 mM Tris (pH 8.0), and 
12.5% glycerol. The trays were set with drop ratios of 1:1, 1:2, and 2:1 of protein to mother liquor 
respectively. Vapor diffusion hanging-drop trays were set at 20 °C to obtain well formed crystals. 
The crystallization solution was found to be an adequate cryoprotectant in subsequent diffraction 
experiments performed at the UNC Biomolecular X-ray Crystallography Facility. The crystals 
were flash frozen in liquid nitrogen for data collection at 100K.  
 Data sets were obtained on the 23_ID_B beamline maintained by The National Institute 
of General Medical Sciences and National Cancer Institute Collaborative Access Team (GM/CA-
CAT) at the Advanced Photon Source (APS) part of the Biosciences Division (BIO) at Argonne 
National Laboratory (ANL). A fluorescence scan was performed at the selenium absorption edge 
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to confirm that the seleno-methione substitution was successful. The collection strategy used 
included 1-second exposures with a 1° rotation between frames. Three data sets were collected at 
the peak, inflection, and remote wavelengths for selenium. The data sets were indexed and scaled 
using HKL-2000 processing software	   6. Indexing resulted in resulted in a space group of P43212 
with one NES C-terminal domain per asymmetric unit. The best data was obtained when the 
resolution was cut to 3.0 Å (Table 4.1). Initial phases were determined using the Phenix software 
suite with the AutoSol function 7. Four of the six heavy atom sites were successfully located. The 
first two heavy metal sites in the protein were disordered resulting in the structure for residues 
255_594. The model was built using Coot 8 by placing the seleno-methiones and iteratively 
building the protein from these starting points. Refinements were performed using the Phenix 
refine application 7. 
4.6 Analysis of the C-terminal Domain Structure 
 Only one C-terminal domain was observed per crystallographic asymmetric unit, 
indicating that this domain functions as a monomer, this conclusion was not in agreement with 
the data from DLS (Figure 4.5) or the size exclusion chromatography experiments (SEC) (data 
not shown) that seem to indicate the presence of an oligomer. This finding can be explained by 
the overall shape of the protein which is contains 15 α-Helices in a convex arrangement (Figure 
4.6). This would make the molecule run like a larger species during SEC experiments and give 
the molecule a larger radius of hydration. The residues 255_294 could be built into the density 
and several loops were disordered. Multiple residues were left as alanine due to the low resolution 
and difficulty in placing the side chains in the difference density maps.  
 The overall fold of this domain contains 15 α-Helices arranged in a convex formation 
(Figure 4.6). The structure appears to be a domain swap in the secondary structure where the 
secondary structure of α1-4 are in a similar arrangement to α5-10. Observing the structure from 
above (Figure 4.6) it is clear that the helices are arranged in a convex shape. Since we are 
currently not able to assign function to this domain we are currently operating under the 
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assumption that is a docking domain that interacts with other members of the relaxosome or 
transportation machinery.  
4.7 SAXS Data Collection and Analysis 
 In order to better understand the arrangement of the two domains of NES we employed 
small-angle X-ray scattering (SAXS) to determine the molecular envelope. A sample of full-
length NES in complex with DNA was sent to Rigaku (The Woodlands, TX) for analysis. 
Through determining what the molecular envelope for the full-length protein looked like we 
hoped to be able to place both domains in the correct orientation and perhaps gain some insights 
into the C-term function.  
 The samples were studied using a BioSAXS-1000 system connected to a Rigaku FR-E+ 
X-ray generator. Data were collected for silver behenate (AgBeh), a common powder compound 
often used to calibrate both powder diffraction and SAXS instruments. AgBeh data collected on 
this instrument for 10 seconds were used to determine the beam center location and to calibrate 
the pixel-to-q conversion. Calibration of q and the direct beam position was carried out in the 
program SAXSLab automatically. For each sample, the original concentration (100%) and two 
dilutions corresponding to 50% and 25% of the original were prepared. Prior to SAXS 
measurements, ~30 µl of each sample dilution was centrifuged for 10 minutes using a 
microcentrifuge. then, 23 µl of each sample or buffer was pipetted inside a sample cell (i.e., a 
quartz capillary in a special holder), and all 3 sample cells were put inside the BioSAXS-1000. 
For each sample and buffer measurement, duplicate scans of 5 min and 15 min were collected. 
All data were collected at room temperature (20°C, in a temperature controlled sample holder). 
Sample and buffer images were converted from pixel space to q-space and averaged to produce 
1D plots of ‘I vs. q’ using SAXSLab which was calibrated with a AgBeh standard. Duplicate ‘I vs. 
q’ plots were averaged together and the averaged buffer plots were subtracted from the averaged 
sample plots in the SAXSLab software. 
 Consecutive, duplicate scans of 5 and 15 minutes were collected for the highest 
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concentration of NES 665 + DNA. The scattering profiles for these initial exposures, shown in 
Figure 4.7, were scaled for display purposes. The averaged 5 minute scan demonstrates that the 
original solution was not aggregated, while the averaged 15 min exposure shows that X-rays did 
not cause any sample aggregation. This is confirmed by the radius of gyration (Rg) calculated 
from Guinier plots. The values listed in Table 4.2 are consistent at about 39.5 Å for both 
exposures. Lastly, note that the values for I0 match from both exposure times. Figure 4.8 shows 
that the Guinier plots for all three concentrations are linear, indicating that the protein molecules 
are mono-dispersed, and the Rg remains consistent with an average value of 40 Å (Table 4.2). 
Also, note that the I0 values for the 50% and 25% dilutions are half of the 100% and 50% 
concentrations, respectively, as expected.  
 Scattering data were collected on three concentrations of NES Figure 4.9.A shows the 
scattering data for all three solutions at 20°C; the scattering plots are superimposable, but they are 
scaled for display purposes. The scattering profile for the 100% solution shows the excellent 
quality of the data with little noise for the entire range of q (Figure 4.9.A). For q > 0.2, the noise 
increases with the sample dilution. A prominent peak in a Kratky plot is an indicator of a compact, 
or properly folded, sample. All Kratky plots show a single peak (Figure 4.9.B), so NES 665 + 
DNA appears to be folded. 
 The structural parameters calculated for NES 665 + DNA are listed in Table 4.3. Rg 
values were determined manually, using Guinier plots shown in Figure 4.8, and using the real-
space Pair-Distance Distribution Function (PDDF) plots calculated by GNOM (Figure 4.10). The 
molecular weights (MW) were estimated from the Porod volume by using the program 
datPOROD and the webtool SAXSMoW–which is provided by the University of São Carlos, 
Brazil (http://www.ifsc.usp.br/~saxs/saxsmow.html)  9. Both programs use GNOM files as input. 
For SAXSMoW, data up to a q value of 0.15 Å-1 were used. The Rg and Dmax values estimated 
by GNOM remain consistent for all three concentrations at about 41 Å and 140 Å, respectively. 
Moreover, there is nice agreement between the Guinier and real-space Rg values. The average 
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MW values estimated from datPOROD (87 kDa) and SAXSMoW (110 kDa) indicate that NES 
665 + DNA is a monomer. Figure 4.10 shows the PDDF plot and the corresponding fit to the 
experimental scattering data for the 100% concentration of NES 665 + DNA. Figure 4.10.A 
shows visually how closely the idealized curves fit the data. Figure 4.10.B, the three PDDF 
shapes remain mostly unchanged and superimposable, with a prominent peak position at 33 Å. 
These results are considered just short of excellent according to the GNOM solution quality 
scores (87-88%) in Table 4.3. 
 Using the data generated form the initial analysis by Rigaku we set about to calculate the 
molecular envelope for the molecule. DAMMIF 10 was first used for rapid ab initio shape 
determination by simulated annealing using a single phase dummy atom model. This program 
works to construct the molecular envelope through adjusting an arbitrary starting volume of 
particles to match the GNOM data. The program was run 30 times to generate a sufficient amount 
of models for accurate averaging. The DAMAVER 11 suite was programs was used to 
superimpose and average the bead models to remove any features that are not representative of 
the true envelope. Lastly, SUPCOMB 12 was used to attempt to place both models. Unfortunately, 
this was not possible due to the fact we had two separate domains with no insights as to how they 
fit together. The averaged envelope generated from DAMAVER was manually fit with the 
relaxase and C-terminal domain (Figure 4.11). Future studies will be conducted in order to get 
SAXS data for the separate domains as well as full length NES without DNA to facilitate our 
understand of the domain arrangement in NES.  
4.8 Conclusions 
 Although prediction servers were not able to identify any similar sequences or secondary 
structures in the literature to date, we set out to determine the structure of the C-terminal domain 
in hopes of identifying a possible function for this domain. By using limited proteolysis and N-
terminal  sequencing we were able to identify a well folded, but unstable, C-terminal domain of 
NES. This was confirmed through CD and DLS, which indicated a protein that was highly α-
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Helical in nature but fairly unstable due to the low Tm and polydispersity. Multiple constructs 
were designed and through X-ray crystallography we were able to determine the structure of the 
C-terminal domain of NES (residues 243_594) but not assign any biological function. This is 
unusual for a relaxase as the other enzymes studied to date show some sort of DNA processing 
domain at the C-terminus. We hypothesize that this domain is a scaffold, responsible for binding 
to another enzyme either in the relaxosome or part of the transfer proteins. To further investigate 
the domain arrangement we employed SAXS to determine the molecular envelope. The initial 
envelope showed an elongated orientation of the two domains indicating that the C-term does not 
play a role in processing the oriT DNA. Thus, we conclude that the C-term is not involved in 
DNA processing and is most like a structural domain. Further work will be conducted to identify 
the binding partner and assign a function to the C-term. 
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Data Collection 
X-ray source GM/CA-CAT GM/CA-CAT GM/CA-CAT 
Space Group P 43 21 2 P 43 21 2 P 43 21 2 
Unit cell: a,b,c (Å); α,β,γ (°) 75.7, 75.7, 181;  90, 90, 90 
75.7, 75.7, 181;  
90, 90, 90 
75.7, 75.7, 181;  
90, 90, 90 
Data Set NES 243-594 PEAK 
NES 243-594 
INFLECTION 
NES 243-594 
REMOTE 
Wavelength (Å) 0.97926 0.97949 0.94928 
Resolution (Å)  
(highest shell) 
100.0-3.00 
(2.90-2.95) 
100 – 3.0 
(2.90-2.95) 
100 – 3.0 
(2.90-2.95) 
I/σ 26 (3.6) 29 (4.8) 31 (3.8) 
Completeness (%) 100 (99.7) 100 (99.7) 100 (99.7) 
Redundancy 9 9 9 
Refinement 
Resolution (Å) 20.0 – 3.0 
No. reflections 10,985 
Rwork 25.5 
Rfree 32.7 
Molecules per asymmetric unit (AU) 1 
No. of amino acids per AU 339 
No. of waters per AU 0 
Average B-factors 79.8 
R.M.S. deviations 
Bond lengths (Å) 0.003 
Bond angles (°) 0.739 
Ramachandran (%) 
Preferred 80.1 
Allowed 10.0 
Outliers 10.0 
Table 4.1 Crystallographic Statistics 
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Conc. Exposure Time (min.) Rg (Å) (error) Guinier Data Points Used I0 (error) 
100% 5 10 
39.4 (0.5) 
39.8 (0.3) 
3-17 
1-17 
3.6 (0.03) 
3.7 (0.02) 
50% 5 10 
40.4 (0.7) 
40.1 (0.5) 
3-17 
1-17 
1.9 (0.03) 
1.9 (0.02) 
25% 5 10 
39.8 (1.2) 
39.3 (0.7) 
4-17 
4-17 
0.88 (0.02) 
0.89 (0.01) 
Table 4.2 Radius of Gyration for NES 665 + DNA at 2 Exposure Times 
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Conc. 
Gunier 
Rg(Å) 
(error) 
GNOM 
Rg (Å) (error) 
Dmax (Å) 
GNOM 
Pts 
used by 
GNOM 
GNOM 
solution 
quality (%) 
MW (kDa) 
datPOROD* 
MW (kDa) 
SAXSMoW 
100% 39.8 (0.3) 41.2(0.2) 142 1-175 86.6 86 113 
50% 40.1 (0.5) 41.4(0.3) 140 1-151 87.7 86 112 
25% 39.3 (0.7) 41.1(0.5) 139 4-105 88.2 90 106 
Table 4.3 Structural Parameters Obtained for NES 665 + DNA 
These data were obtained using the 15 minute exposure time at 20° C. *Calculated by dividing 
the Porod volume by 1.7 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A 
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NES 665+DNA 
NES 665+DNA 
75 kD 
50 kD 
50 kD 
75 kD 
NES 665 
NES 665 
Figure 4.1 Limited Proteolysis of NES 665 
 
SDS-PAGE gels of limited proteolysis performed on NES 665 and NES 665 + DNA. A. 
Limited proteolysis performed with Trypsin. B. Limited proteolysis performed with 
proteinase K. 
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Figure 4.2 N-Terminal Sequencing Results on Proteolysis Fragment 
 
Yellow residues represent the highest percentage in sequencing results. An x signifies no 
data. The NES sequence that corresponds is shown below.  
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NES Sequence - k h n e s i k k r n q 
228 238 
94 
NES 228_643 
NES 228_594 
NES 228_560 
NES 228_512 
NES 228_665 Relaxase 
NES 228_643 Relaxase 
NES 228_594 Relaxase 
NES 228_560 Relaxase 
NES 228_512 Relaxase 
NES 228_591 
NES 228_581 
Figure 4.3 NES Crystallization Constructs 
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Figure 4.4 Circular Dichroism Analysis of NES 228_594 
 
A. CD wavelength scan of NES 228_594 at 5 µM. B. Thermal denaturation of NES 220 
monitoring the change in CD signal (mdeg) at 208 and 222 nM.  
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Item  R (nm)  %Pd             MW-R (kDa)  %Int               %Mass  
Peak 1  5.4  17.6  172  97.6                   99.0 
Peak 2  530.2  20.5  7977510        1.7                     0.1 
Peak 3  21753.3  36.0  47437100000  0.7  1.0 
 
Figure 4.5 Dynamic Light Scattering of NES 228_594 
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90° 
Figure 4.6 X-ray Crystal Structure of the C-terminal Domain of NES 
 
The structure was determined to 3.0 Å. The magenta residues represent the N-term and the 
cyan residues represent the C-term.  
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Figure 4.7 SAXS Scattering Profiles 
 
Scattering profiles for 10.6 mg/ml (100%) NES 665 + DNA at 5 and 15 minutes at 20°C. 
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Figure 4.8 Guinier plots for all concentrations of NES 665 + DNA 
 
Data is from a 15 min. exposure at 20° C. A. Data from 100% concentration. B. Data from 
50% concentration. C. Data from 25% concentration.  
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Figure 4.9 Scattering Profiles and Kratky Plots for NES 665 + DNA  
 
Data from 3 concentrations of NES 665 + DNA with a 15 min. exposure time at 20°C. A. 
Scaled scattering profiles. B. Kratky plots for each concentration.  
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Figure 4.10 Fits to experimental data from GNOM and PDDF plots for NES 665 + DNA 
 
A . GNOM fit to experimental data at the 100% concentration. B. PDDF plots for all 
concentrations with the Y-axis normalized for visual comparison.  
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Figure 4.11 Averaged SAXS Molecular Envelope for NES 665 + DNA 
 
The averaged molecular envelope with the structures of both domains of NES manually fit 
into the shell.  
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Chapter 5 
 
 Immobilization of Active Human Carboxylesterase 1 in Biomimetic Silica Nanoparticles* 
 
5.1 Introduction 
Sol-gel and biomimetic reactions have facilitated the use of immobilized enzymes in a 
range of applications 1. For example, several recent studies have employed the biomineralization 
of silica to encapsulate a variety of enzymes. This reaction occurs rapidly at room temperature 
using tetramethylorthosilicate (TMOS) and a polycationic catalyst to promote silica formation 
around the target enzyme.  Proteins encapsulated using this approach can be used to catalyze 
highly specific reactions, to screen for enzyme inhibitors, or to detect the presence of chemical 
compounds. Indeed, silica particles containing enzymes have been employed in biosensing 
applications, including microfluidic devices and aerosol detectors 2-3. 
There are several advantages to using silica particles for encapsulation, including the fact 
that the mild reaction conditions promote the capture of active enzymes, and, in some cases, 
increase enzyme stability 4. The simplicity and speed of the reaction also allow for rapid 
encapsulation and the cost-effective production of the particles for various needs. For example, 
encapsulated enzymes could be used in a column format to monitor for chemical contaminants in 
water sources. However, encapsulation efficiency varies with the catalyst-enzyme pair 5. Thus, 
optimal encapsulation conditions must be identified for each enzyme before they can be applied 
in a useful setting. 
One promising application of encapsulated protein is the detection of chemical 
compounds, such as organophosphates (OP).  OPs are employed as agricultural pesticides, but  
*Edwards, J. S. et al. Immobilization of active human carboxylesterase 1 in biomimetic silica 
nanoparticles. Biotechnol Prog 27, 863-869, doi:10.1002/btpr.604 (2011). 
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have also been weaponized for use as highly toxic nerve agents like sarin, soman, and cyclosarin 
6-7. OP toxicity arises from the noncompetitive inhibition of acetylcholinsterase (AChE), which 
produces sustained acetylcholine stimulus of the muscarinic and nicotinic receptors and may lead 
to diaphragm incapacitation resulting in suffocation. Biosensors containing enzymes inhibited by 
OPs have recently been explored for military and civilian applications 2,8,9. 
The human liver carboxylesterase 1 (hCE1) is a promiscuous serine hydrolase that catalyzes the 
hydrolysis of endogenous molecules and xenobiotics containing ester, amide, or thioester bonds 
10-17. This structural AChE homolog is currently being explored as a prophylactic bioscavenger to 
decontaminate OP toxicity 18. Based upon the ability of hCE1 to bind Ops 15,18, we sought to 
examine the silica encapsulation of hCE1 and the ability of the resultant nanoparticles to detect 
the presence of OP toxicants. 
5.2 Methodology 
 Expression and purification of hCE1. A secreted form of hCE1 was expressed using 
baculovirus infection of Spodptera frugiperda Sf21 cells and purified as described 19. hCE1 was 
concentrated in 50 mM HEPES (pH 7.4) and stored at 4 oC. Protein concentration was determined 
spectrophotometrically using an extinction coefficient 17700 M-1 cm-1 (NanoDrop, ND-1000 
Spectrophotometer). 
 Preparation of silica nanoparticles with hCE1. All materials were purchased from 
Sigma-Aldrich unless otherwise noted. A stock solution of lysozyme at 100 mg/mL was prepared 
in 0.1 M potassium phosphate buffer (pH 7.4). A solution of hydrolyzed tetramethyl orthosilicate 
(TMOS) was freshly prepared by diluting into 1 mM hydrochloric acid to a final concentration of 
1 M. A typical reaction mixture consisted of 800 µL of 0.1 M potassium phosphate buffer 
containing 5 µg of hCE1, 100 µL of lysozyme or R5 solution (100 mg/mL), and 100 µL of 1 M 
hydrolyzed TMOS. The mixture was incubated at room temperature (22o C) for 10 minutes with 
gentle shaking. The slurry was centrifuged for 60 s (13,000 rpm) to remove the particles and 
washed in ddH2O three times. Control particles were produced in a similar manner using a 
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reaction mixture without hCE1 by combining 800 µL of 0.1 M potassium phosphate buffer, 100 
µl of lysozyme solution, and 100 µL of hydrolyzed TMOS. Combination particles were created 
using ratios of polyethyleneimine (1%) to lysozyme (100 mg/mL) 1:4, 1:1, 4:1 as the catalyst to 
compare the efficiency of enzyme incorporation. The total volume of catalyst used was always 
equal to 10% of the silica reaction.  
 Scanning and transmission electron microscopy. The morphology of silica-encapsulated 
hCE1 with various catalyst was observed with a Hitachi 4700 Scanning Electron Microscope 
(SEM) and a JEOL 2010F Transmission Electron Microscope (TEM). SEM samples were 
prepared by depositing dry powdered samples on a double-stick carbon tape on an aluminium 
SEM sample holder. The samples were coated with a 3nm Au-Pd conductive coating in order to 
prevent charging effect during imaging. TEM samples were prepared by air-drying a drop of 
concentrated reaction mixture on a carbon-stabilized copper grid (Ted Pella Inc.). 
 Determination of hCE1 enzyme activity. Activity of silica-encapsulated or solution hCE1 
were monitored using para-nitrophenyl butyrate (pNPB) as a substrate and measuring the 
absorbance of the para-nitrophenol product at 410 nm using a Pherastar spectrophotometer (BMG 
Labtech). The substrate was dissolved in ethanol to a concentration of 1 M, and then diluted to 10 
mM in 0.1 M phosphate buffer pH 7.4. hCE1 silica particles were mixed with substrate at a final 
concentration of 5 mM. Supernatants from the washes were saved and monitored in the same 
fashion to determine the incorporation efficiency of the silica reactions.  
 Kinetics of para-nitrophenyl butyrate hydrolysis.  Km, Vmax, and kcat values were 
determined by monitoring the conversion of pNPB to para-nitrophenol at 410 nm using a 
Pherastar spectrophotometer (BMG Labtech). Substrate was prepared as described above. Data 
was collected over 4 minutes and the linear portions were used for the linear regressions to 
calculate the reaction velocities. Kinetic parameters were determined by plotting the reaction 
velocities versus substrate concentration. An extinction coefficient of 17700 was used for para-
nitrophenol in calculating the Vmax. The molecular weight for hCE1 that was used to calculate 
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the kcat was 61.68 kDa. The Prism software packaged was used to fit the data (GraphPad, San 
Diego, CA). 
 Column-based experiments. Column activity of silica-encapsulated hCE1 was determined 
using a stainless steel microbore column (2 cm x 2 mm, Upchurch Scientific, Oak Harbor, WA) 
with 0.5 µm frits. The silica nanoparticle reaction mixture was scaled up to a total of 10 mL. The 
particles were resuspended in 0.1 M phosphate buffer pH 7.4 and pumped at a flow rate of 10 
µL/min to pack the column. The column was washed with 10 column volumes of phosphate 
buffer prior to use. All column experiments were performed at room temperature (22 oC) at a 
flow rate of 100 µL/min using a NE-1000 syringe pump (New Era Pump Systems, Wantagh, NY).  
Phosphate buffer containing 5 mM substrate was flowed through the column. Samples were 
collected and analyzed in a Pherastar spectrophotometer to measure absorbance at 410 nm until 
the substrate hydrolysis had reached a maximum.  
 Organophosphate pesticide detection. Using a column constructed in the manner 
described above, phosphate buffer containing 5 mM substrate was applied and absorbance was 
measured until the substrate hydrolysis reached its maximum value. Phosphate buffer containing 
5 mM substrate and paraoxon or DMPNPP (1mM) was then flowed through the column, and 
absorbance was measured at 410 nm to determine if OP was detected. A drop in absorbance at 
410 nm correlates with enzyme inhibition because the product of the enzyme assay, para-
nitrophenol, absorbs at 410 nm. The pesticides were diluted 1:10 in methanol and further diluted 
in 0.1 M phosphate buffer pH 7.4 to their final concentration. Inhibition was confirmed by 
flowing phosphate buffer containing 5 mM substrate through the column and monitoring 
absorbance at 410 nm. 
5.3 Results 
5.3.1 Silica Encapsulation of Active hCE1 
Initial experiments employed lysozyme as the polycation catalyst for silica nanoparticle 
formation in reaction conditions containing hydrolyzed tetramethylorthosilicate (TMOS), 
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lysozyme (100 mg/mL), and potassium phosphate buffer at pH 7.4 with 5 µg of hCE1 enzyme. 
hCE1 was incorporated into the particles with high efficiency, leaving no enzyme activity in the 
supernatant (Figure 5.1.A).  In addition, no hCE1 activity was detected in solutions used to wash 
the particles after formation (Figure 5.1.A).  Thus, while the process may render some hCE1 
inactive, all detectable enzyme activity localized solely to the particles.  hCE1 activity in the 
silica nanoparticles, as measured by para-nitrophenyl butyrate (pNPB) hydrolysis,  reached the 
same maximal velocity as 5 µg of hCE1 in solution; however, the encapsulated enzyme exhibited 
a slightly reduced initial rate of product formation (Figure 5.1.A, Table 5.1). Multiple washes of 
silica particles with phosphate buffer did not release active enzyme, indicating that the hCE1 
activity associated with the particles did not arise from enzyme adhered relatively loosely to 
particle surfaces. Similarly, several washes of particles in 1% Tween 20 did not dissociate hCE1 
activity from the particles (data not shown). When washed in detergent, the hCE1 activity in the 
particles was comparable to the activity measured from particles washed in buffer alone (Table 
5.1).  
We examined the effect of entrapping hCE1 in silica on the enzyme’s ability to hydrolyze 
pNPB. Kinetic experiments were performed maintaining a constant amount of enzyme with 
varied substrate concentrations to determine initial reaction velocities. Michaelis-Menten kinetics 
was assumed and the kinetic parameters were determined (Table 5.2).  hCE1 in silica had a Km 
that was approximately three times higher than enzyme in solution. Furthermore, hCE1 in silica 
exhibited a slightly reduced efficiency (kcat/Km = 3.1 x 104 s-1M-1) relative to free enzyme (kcat/Km 
= 1.9 x 104 s-1M-1). These solution values are in agreement with previously reported kinetic 
parameters for hCE1 with para-nitrophenyl butyrate (pNPB) 20. Taken together, these results 
demonstrate that active hCE1 can be efficiently incorporated into lysozyme-catalyzed silica 
nanoparticles.  
 We also investigated the ability of other cationic catalysts to generate hCE1-encapsulated 
silica nanoparticles. We created silica particles in the presence of hCE1using the following 
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catalysts: cationic peptide R5 (NH2-SSKKSGSYSGSKGSKRRIL-CO2H)21 and the polymer 
polyethyleneimine (PEI). We found that silica particles formed with the R5 peptide exhibited 
similar incorporation efficiency and enzyme activity as the lysozyme hCE1-silica particles 
(Figure 5.1.B, Table 5.1).  In contrast, PEI catalyzed particles, which formed immediately upon 
mixing (compared to ~5 minutes with the lysozyme or R5 silica particles) excluded hCE1 into the 
supernatant and thus had no associated enzyme activity with the particles. (Figure 5.1.C; Table 
5.1).   
 We hypothesized that the lack of entrapped hCE1 during PEI-mediated particle creation 
was caused by either the rapid particle formation or catalyst size.  That hypothesis was tested by 
creating beads using different ratios of lysozyme and PEI in the presence of the same amount of 
hCE1 (80% lysozyme:20% PEI, 50% lysozyme:50% PEI, and 20% lysozyme:80% PEI). It was 
determined that increasing the amount of lysozme relative to PEI improved the encapsulation of 
hCE1, but that no silica particles formed in the presence of PEI exhibited higher levels of 
entrapped hCE1 activity than those formed without PEI (Figure 5.1.D-F, Table 5.1). We also 
concluded that hCE1 alone could not facilitate the precipitation of silica particles without either 
lysozyme or the R5 peptide (data not shown).  The reaction was cooled to 4° C to see if the silica 
condensation could be slowed in the presence of PEI. The reaction appeared to occur just as fast 
and no hCE1 was incorporated into the particles (data not shown). Thus, we conclude that 
macromolecular catalysts as small as the R5 peptide and as large as hen egg white lysozyme are 
capable of generating silica nanoparticles that entrap active hCE1. 
5.3.2 Electron Microscopy of hCE1 Nanoparticles 
We employed scanning electron microscopy (SEM) and transmission electron 
microscopy (TEM) to examine the size and morphology of silica particles produced in the 
presence of hCE1. Silica hCE1 particles using lysozyme as the catalyst were larger than the 
particles obtained using either R5 or PEI as catalysts. Lysozyme-catalyzed particles were 0.8-1 
µm in diameter and appeared to fuse to form large aggregates on the order of ~ 2 µm (Figure 
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5.2.A). In contrast, silica particles obtained in the presence of hCE1 using R5 and PEI as catalysts 
formed individual particles 0.3-0.8 µm in diameter and an aggregate size of ~ 1 µm (Figure 5.2.B-
C). Dynamic light scattering (DLS) performed on the lysozyme catalyzed silica particles 
confirmed the sizes measured from SEM analysis (data not shown).  The silica particles formed 
using the combinations of lysozyme and PEI were smaller (~ 0.5 µm) and appear monodisperse 
as compared to the particles using only lysozyme or PEI as catalysts (Figure 5.2.D-F). Increasing 
amounts of PEI in the reaction lead to the formation of smaller particles and smaller aggregate 
size.   
 TEM images corroborated the SEM data (Figure 5.3.A-B). For example, particles 
obtained in the presence of lysozyme were larger in size compared to that of the PEI-catalyzed 
silica particles. Further, the TEM images revealed that the lysozyme-catalyzed silica particles 
exhibited a smoother surface than that of the PEI-catalyzed particles. In contrast, the particles 
obtained using ratios of lysozyme and PEI as catalysts, appeared to have rougher surface features 
similar to that seen for the PEI catalyzed particles. This was presumably due to the presence of 
PEI on the particle surface (Figure 5.3.C-E). 
5.3.3 Solution Detection Studies of Pesticides with hCE1 Nanoparticles 
We examined whether silica nanoparticles containing active hCE1 could function in a 
column chromatography format.  Biosilica particles formed with lysozyme and hCE1 (Figure 
5.1.A, Figure 5.2.A) were packed using buffer flowed into a stainless steel microbore column (2 
cm x 2 mm) with 0.5 µm frits controlled by a New Era single syringe pump (New Era Pump 
Systems, Wantagh, NY).  Particles catalyzed with lysozyme in the presence of hCE1 were chosen 
because they were cost-effective and displayed robust entrapment efficiency and enzyme activity. 
After extensive washing of the column, 5 mM pNPB was applied to the column and para-
nitrophenol formation was observed, indicating that hCE1 retains its enzyme activity in the silica 
particles packed within the column (Figure 5.4).  No hCE1 activity was detected in the solutions 
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used to wash the column, supporting the conclusion that the enzyme remained encapsulated in the 
column particles.   
 To determine whether columns containing hCE1 biosilica nanoparticles were capable of 
detecting organophosphate pesticides, we added the pesticides and monitored substrate 
conversion to para-nitrophenol.  Columns were operated in the manner described above, and 
equilibrated such that a stable amount of para-nitrophenol product was being formed over time 
(e.g. 10 µmol/min.). At that point, 1 mM diethyl para-nitrophenyl phosphate (paraoxon) was 
applied to a column, which produced a dramatic drop in enzyme activity resulting in decreased 
substrate conversion (Figure 5.4.A). Detection of the presence of this hCE1 inhibitor occurs 
rapidly, likely due to the small column volume of 16.2 mL. hCE1 remains permanently inhibited 
by paraoxon even 50 minutes (~70 column volumes) after this inhibitor is removed from the 
substrate-containing solution applied to the column (Figure 5.4.A).  In a second study, dimethyl-
para-nitrophenylphosphate (DMPNPP) was applied to a column instead of paraoxon. In this case, 
detection of the hCE1 inhibitor was rapid, but once the inhibitor was removed, hCE1 activity 
returned over time (Figure 5.4.B). Paraoxon inhibits hCE1 activity 3-fold more robustly in 
solution than DMPNPP (with bimolecular rates of inhibition [ki] values of 9.1 ± 0.5 x 106 min-1 
M-1 and 2.9 ± 0.3 x 106 min-1M-1, respectively) 18. Taken together, these results indicate that OP 
pesticides can be detected using hCE1 biosilica nanoparticles within a column chromatography 
format. 
5.4 Conclusions 
Silica nanoparticles have the potential to generate a range of platforms for biodetection. 
We have shown that hCE1 can be effectively encapsulated into silica nanoparticles catalyzed by 
lysozyme, and that these particles maintain overall enzyme activity comparable to hCE1 in 
solution. In our studies, however, lysozyme-encapsulated hCE1 exhibited a slightly reduced 
initial rate of product formation, although activity reached that of free hCE1 over time. We 
hypothesize that this effect is caused by impeded substrate access to the active site of the enzyme 
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in the silica matrix. We also found that hCE1 is more efficiently incorporated into silica 
nanoparticles using lysozyme as a catalyst in comparison to PEI catalyzed silica particles. Similar 
results have been observed with other enzymes during encapsulation 5. 
 We focused on three catalysts – lysozyme, the R5 peptide, and PEI – which have been 
demonstrated to be successful in previous studies with other target enzymes 22-24. Based on our 
results, we hypothesize that the lack of entrapped hCE1 during PEI-mediated particle creation 
was caused by the rapid particle formation and the small size of PEI. For example, when 
lysozyme was used as a catalyst, the reaction proceeded slowly taking approximately 2 minutes 
until particles can be visualized in solution; in contrast, when PEI was employed, the particles 
formed immediately. This observation, combined with the smaller sized PEI-catalyzed particles 
relative to those created with lysozyme suggested that PEI-generated silica matrixes excluded 
hCE1 under the reaction conditions employed. The lysozyme-catalyzed particles underwent more 
complete condensation similar to that seen for pure sol-gel silica reactions with other enzymes25.  
 Finally, we demonstrated that silica nanoparticles containing hCE1 are able to detect OP 
pesticides in a column chromatography format.  The drop in hCE1 activity correlated with the 
strength of the inhibitor employed; for example, paraoxon, a more potent hCE1 inhibitor, did not 
allow enzyme activity to recover during the time course of the study.  It is possible that such an 
apparatus could be employed in the detection of OP pesticides or chemical weapons agents using 
silica nanoparticles containing hCE1. Both liquid- and gas-based detection have already been 
reported involving other enzymes, including the cholinesterases 2.  Our data indicate that another 
member of the serine hydrolase family of enzymes may also be employed for this or related 
technologies. 
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Sample hCE1 Activity (moles of nitrophenol/second) R
2 
hCE1 in solution 3.42 x 10-7 0.99 
Lysozyme 2.74 x 10-7 0.99 
R5 2.90 x 10-7 0.99 
PEI NA  
80% Lysozyme,  
20% PEI 2.52 x 10
-7 0.99 
50% Lysozyme,  
50% PEI 3.03 x 10
-8 0.99 
20% Lysozyme,  
80% PEI NA 
 
 
Lysozyme washed with 
1% Tween 20 1.50 x 10
-7 0.99 
hCE1 Solution with 1% 
Tween 20 6.04 x 10
-8 0.99 
Table 5.1 hCE1 rate of pNBP hydrolysis in solution compared to silica particles created with 
different catalysts. NA: not applicable, no enzyme activity contained in the particles. 
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Km (mM) 3.30 ± 0.44 10.13 ± 0.85 
Vmax (µmole/min/mg) 97.71 ± 4.84 189.72 ± 7.41 
Curve Fit (r2) 0.99 0.99 
kcat/Km (s-1 M-1) 6.09 x 104 3.85 x 104 
Table 5.2 Kinetic parameters for the metabolism of pNPB by hCE1 in solution and in lysozyme 
catalyzed silica particles. N=3, S.E. for Km and Vmax values. 
hCE1 in Solution 
Silica Particles 
Silica Supernatant 
A B 
C D 
E F 
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Figure 5.1 hCE1 Activity in Silica Nanoparticles 
 
Activity assays measuring the formation of para-nitrophenol at 410 nm. Silica particles were 
formed using the respective catalysts and the absorbance was measured over time. Activity was 
measured for the silica particles and the supernatant from the reaction, then compared to hCE1 
in solution. All data points had an N = 3 and S.E. is reported.  
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Figure 5.2 Kinetic Parameters for the Metabolism of pNPB by hCE1 
 
SEM images of the silica particles containing hCE1 at two magnifications. The samples were  
sputtered with Au-Pd conductive coating prior to analyses.  
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Figure 5.3 hCE1 TEM Images of Silica Nanoparticles 
 
TEM images of the hCE1 encapsulated silica particles at two magnifications. Particles were 
air dried on a carbon stabilized copper grid prior to imaging.  
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A 
B 
Figure 5.4 Microbore Column Detection of Pesticides 
 
Microbore columns packed with lysozyme catalyzed silica particles containing hCE1 at a 
concentration of 8.065 x 10-2 nmol used to detect pesticides. The columns were equilibrated at 
25° C to maximum activity with 5 mM substrate before 1 mM pesticide was applied (grey 
box). The eluent from the column was collected and measured in triplicate at the respective 
time points. All data points had an N = 3 and S.E. is reported.  
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Chapter 6 
 Nerve Agent Hydrolysis Activity Designed into a Human Drug Metabolism Enzyme* 
6.1 Introduction 
Organophosphorus (OP) nerve agents are some of the most poisonous chemicals known 
(Figure 6.1.A) 1. By covalently phosphonylating the catalytic serine of the neurotransmitter-
regulating enzyme acetylcholinesterase (AChE), OPs produce a cholinergic crisis that can cause 
respiratory failure and death 2. OP nerve agents have been used as chemical weapons by both 
established governments and terrorist groups 2,3.  In addition, there are an estimated 250,000 
deaths worldwide each year associated with OP pesticides 4.  Thus, there is significant interest in 
developing novel approaches to detoxify these compounds for military, security and clinical 
applications 5. 
 Human carboxylesterase 1 (hCE1) is primarily expressed in the liver and metabolizes a 
variety of chemically distinct substrates, from potentially harmful endogenous compounds to 
exogenous compounds including drugs and environmental toxins 6.  hCE1 is homologous in 
structure and catalytic mechanism to AChE and exhibits features that make it attractive as a 
potential nerve agent hydrolase 6. Both hCE1 and AChE employ a catalytic triad consisting of 
serine, histidine, and glutamic acid residues.  In addition, for both enzymes, OP nerve agents act 
as hemisubstrates – compounds that can start but not complete a reaction cycle to regenerate free 
active enzyme 7-9.  Indeed, hCE1 is potently inhibited by nerve agents, forming long-lived 
covalent phosphonyl-enzyme complexes (Figure 6.1.B) 8.  We have previously shown that hCE1 
does not undergo the dead-end “aging” process from this intermediate that is observed for the 
*Hemmert, A. C. et al. Nerve agent hydrolysis activity designed into a human drug metabolism 
enzyme. PLoS One 6, e17441, doi:10.1371/journal.pone.0017441 (2011). 
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cholinesterases, AChE or butyrylcholinesterase (BChE) 10.  In addition, wild-type (wt) hCE1 
exhibits a slow hydrolysis-based reactivation after exposure to sarin, but no reactivation is 
observed when hCE1 is exposed to soman or cyclosarin 8.  
 Thus, we sought to design an hCE1 variant capable of hydrolyzing OP nerve agents.  We 
employed molecular modeling techniques based on crystal structures of hCE1 in trapped covalent 
complexes with agents to engineer amino acids capable of promoting dephosphonylation.  Herein, 
we report the placement of a pair of residues in the hCE1 active site that significantly increases 
the rate of nerve agent hydrolysis relative to native hCE1, while still retaining high affinity and 
selective functional substrate activity towards these compounds.  Thus, using only two amino 
acid changes, we have created one of the most efficient enzymes engineered to date with respect 
to converting hemisubstrates into substrates. 
6.2 Methodology 
 hCE1 Mutagenesis, Expression, and Purification.  Site-directed mutagenesis was done 
using PCR to introduce the desired amino acid changes into hCE1 (Genbank accession M73499). 
Briefly, 100 pM of both sense and anti-sense primers were mixed with 50 ng hCE1 cDNA in a 
pUC9 vector, 200 µM dNTPs, 1X Pfu-BSA buffer, and 2 u Pfu (New England Biolabs, Ipswich, 
MA).  Mutations were produced through 15 cycles of PCR, where each cycle consisted of 95o C 
for 1 minute, 58o  C for 30 seconds, and 70o  C for 10 minutes.  The reaction was digested for 1 
hour with Dpn1 (Fermentas, Burlington, Ontario) at 37o C and transformed into chemically 
competent DH5α cells (Invitrogen, Carlsbad, California).  pUC9 plasmids were isolated with a 
GeneJET Plasmid Miniprep kit (Fermentas) and mutations were confirmed by DNA sequencing.  
Once the mutations were successfully incorporated, the 1.7 kB hCE1 cDNA was ligated into 
pCIneo for mammalian cell expression (Promega, Madison, WI). Non-secreted forms of wt and 
mutant hCE1 proteins were expressed in COS-7 cells (American Type Culture Collection, 
Rockville, Maryland) as previously described 11.  Presence of active hCE1 was determined by 
measuring the rate of nitrophenol production in the presence of 3 mM o-nitrophenol acetate 
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through a change in absorbance at 420 nm.  Specific activities were determined by normalizing 
hCE1 activity relative to protein expression as visualized through western blot analysis with an 
anti-hCE1 antibody 11.  To facilitate measurement of additional kinetic constants, secreted forms 
of wt and V146H/L363E hCE1 were expressed in Spodoptera frugiperda Sf21 insect cells 
(Clontech, Palo Alto, California) using baculovirus-expression vectors and purified as previously 
described 24.  
 Examination of Kinetics of hCE1 Variants.  Experiments with all racemic OP nerve 
agents were conducted at the United States Army Medical Research Institute of Chemical 
Defense (USAMRICD), Aberdeen Proving Ground, MD. Nerve agents were obtained from the 
U.S. Army Edgewood Chemical Biological Center (ECBC, Aberdeen Proving Ground, MD).  
Analysis by nuclear magnetic resonance spectroscopy showed them to be > 95% pure.  Dilute 
nerve agent was handled according to safety guidelines in place at USAMRICD.  All kinetic 
assays were conducted at 25° C. In separate experiments, 50 mL of whole cell COS lysates 
expressing an hCE1 mutant was inhibited with a ~1000-fold molar excess of racemic sarin, 
soman, or cyclosarin for 10 minutes.  Unbound agent was removed by passing inhibited samples 
over a CENTRI-SEP size exclusion column (Princeton Separations, Adelphia, NJ).  The column 
eluate was diluted 10-fold in 0.1 M potassium phosphate buffer, pH 7.4.  Aliquots were tested for 
hCE1 carboxylesterase functional activity using 5 mM pNPB and compared to an uninhibited 
sample.  Measurements were taken over 60 hours, and the observed rate of enzyme reactiviation 
(kobs), or the ability of enzyme to hydrolyze pNPB, and maximal percent recovery (Amax) were 
determined by fitting the collected data to equation 1: 
A = AO + Amax (1! e!kobst )         (1) 
where A was the percent activity at time t, and A0 was the initial activity at t=0. Reactivation 
experiments were conducted in triplicate and independently replicated.  It should be noted that 
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these experiments gauge reactivation via a second substrate and do not measure OP turnover or 
its products directly. 
Phosphonylated esterases may either spontaneously reactivate or reside in an inactive 
state, which is the aged state 8. However, for wt hCE1 no aging has ever been measured. As 
shown in Figure 6.1.B these two pathways compete as first-order reactions. Therefore, the true 
rate of enzyme dephosphonylation (k3) was determined by equation 2 25: 
k3 = (Amax )(kobs ) /100                       (2) 
where kobs and Amax were defined in eq. 1.  The denominator normalizes for Amax.  All data were 
analyzed in KaleidaGraph 4 (Synergy Software, Reading, PA).  Because the reactivation step 
represented by k3 was the slow step in the OP hydrolysis reaction, k3 effectively represented the 
rate of OP turnover. 
To determine the bimolecular rate of inhibition (ki) with racemic cyclosarin, 100 nM of 
purified V146H/L363E hCE1 or wt enzyme was exposed to 100-fold excess of cyclosarin and the 
decrease in pNPB hydrolysis was measured over time.  Data were fit to equation 3 and the ki was 
calculated by dividing the rate of phosphonylation (k2) by the cyclosarin concentration:  
A = AOek2t             (3) 
where A is the CE activity at a given time t, and A0 is the enzyme activity prior to cyclosarin 
inhibition.   
Further inhibition kinetics were determined with stereoisomers of OP model compounds, 
where 100 nM of V146H/L363E hCE1 was incubated at room temperature with increasing 
concentrations of inhibitor.  The thiomethylated OPs examined (Figure 6.1.A) have previously 
been shown to form identical adducts to bona fide nerve agents 8,13.  These compounds were 
generously provided by Dr. John Cashman at the Human BioMolecular Research Institute and 
their synthesis is described by Gilley et al. 13. Aliquots of enzyme in the presence of sarin, soman, 
and cyclosarin model compounds were removed at various time points (up to 1 hour) and the 
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level of remaining enzyme activity was determined by comparing 4-methylumbelliferyl acetate 
(4-MUA) hydrolysis relative to an uninhibited sample. 4-Methylumbelliferone fluorescence 
emission, measured at 450 nm following excitation at 350 nm, was monitored at 37o C on a 
Pherastar microplate reader (BMG Labtech, Cary, NC) and the data were fit to equation 4 26:   
!t
! lnv =
Km
k2
"
1
OP[ ] 1#!( )
+
1
k2
       (4) 
where Km was the nerve agent model Michaelis-Menten constant, k2 the unimolecular 
phosphonylation rate constant, v the remaining percent enzyme activity, and [OP] the OP 
concentration. The term α was defined as [S]/(Km+[S]), in which [S] was the substrate 
concentration and Km was the 4-MUA Michaelis-Menten constant.  For these experiments α was 
0.91.   All experiments were performed in triplicate and data were analyzed to determine ki, 
where ki=k2/Km 16. Again, all data were analyzed in KaleidaGraph 4. 
 Computational Modeling of hCE1 Mutants.  To simulate the hCE1-OP crystal structure 
for computational design, a new residue type was created for S221 covalently inhibited by sarin, 
soman, or cyclosarin. Following removal of all water molecules, saccharides, ligands, and extra 
monomers from the hCE1-cyclosarin homotrimer crystal structure (RSCB PDB 3K9B 8), protein 
hydrogen atoms were added into one monomer with Molprobity 27. OP-inhibited S221 hydrogen 
atoms were added using Accelrys Discovery Studio Visualizer 2.5 (Accelrys, San Diego, CA). 
Any strain or steric interactions in the resulting structure were then removed by performing 50 
steps of conjugate gradient energy minimization.  
Residues with side chains pointing towards and within 5 Å of the OP, V146, or L363 residues 
(using 3K9B numbering, residues 89, 90, 93, 96, 97, 100, 101, 145, 220, 222, 252, 254, 255, 304, 
318, 358, 359, 361, 364, 388, 425, 426, and 468,) were allowed to sample alternative 
conformations during the design phase of the simulation, but their identities were not modified. 
At positions 146 and 363, only histidine or glutamic acid was allowed, respectively.  A standard 
backbone-dependent side chain rotamer library with expansions by one standard deviation about 
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χ1 and χ2 was used 28. The crystallographic conformer at each designed position was also allowed. 
Prior to the modeling procedure, rotamer libraries for the various OPs were generated. The OP 
rotamer libraries introduced torsions in the phosphorus-alkoxy oxygen and alkoxy oxygen-carbon 
bonds of each OP-bound serine residue, in 5° increments. The rotamers with conformational 
energies lower than a specified value (usually 0) were included in the OP rotamer library. 
Computational design was done using the PHOENIX protein design software. The energy 
function used was based on the DREIDING force field 29 and included a scaled van der Waals 
term, hydrogen bonding and electrostatic terms, as well as terms for implicit solvation and phi-psi 
propensities 29. Implicit solvation energies were evaluated using a model based on occluded 
volume. Amino acid phi-psi propensities were derived and applied following the method of 
Shortle 30.  The final model consisted of the lowest energy rotamers for the OP, V146H, L363E, 
and surrounding active site residues. 
6.3 Results 
6.3.1 Structure-Guided Dyad Design 
 To hydrolyze the covalent phosphonyl-enzyme OP-bound species of hCE1, we 
introduced a histidine (H) at position 146 and a glutamic acid (E) at position 363.  These residues 
were chosen because they appeared ideally positioned to order a water molecule for hydrolysis.  
The corresponding wild-type residues V146 and L363 are positioned on either side of the active 
site pocket, adjacent to the OP-serine bond formed during the two-step catalytic mechanism of 
the enzyme (Figure 6.2).  V146 is part of an extended loop between b7 and a2 that also contains 
the oxyanion hole formed by residues G142 and G143.  L363 caps a12, at the edge of the hCE1 
active site. As outlined below, the structurally similar residue glutamine (Q) was used as a control 
mutation for each position. hCE1 mutants were successfully expressed, purified, and shown to 
exhibit enzyme activity using a standard esterase substrate para-nitrophenylbutyrate (pNPB) 11, 
although wildtype hCE1 was ~30-fold faster toward pNPB than the V146H/L363E mutant (660 
nmol/min/mg vs. 21 nmol/min/mg). 
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6.3.2 Enhanced Nerve Agent Hydrolysis 
 The V146H/L363E hCE1 mutant exhibited a significant increase in enzyme reactivation 
following nerve agent inhibition (Figure 6.3.A).  We had shown previously that wild-type (wt) 
hCE1 reactivates following sarin exposure at a rate (k3) of 2.4 ± 0.50 × 10-4 min-1, or a half-time 
of reactivation (t1/2) of 46 hrs, and that wt enzyme was not able to recover following soman or 
cyclosarin inhibition 8.  In contrast, however, the V146H/L363E hCE1 mutant spontaneously 
reactivated following sarin and soman inhibition with rates of 12 ± 2.0 × 10-4 min-1 (t1/2 of 9.5 hrs) 
and 10 ± 1.0 × 10-4 min-1 (t1/2 of 11.5 hrs), respectively.  The reactivation rates of V146H/L363E 
hCE1 after sarin and soman inhibition were 5- and 20-fold faster, respectively, than the wt 
enzyme. Most strikingly, the designed V146H/L363E dyad exhibited a rate of reactivation of 67 ± 
6.0 × 10-4 min-1 (t1/2 of 1.2 hr) following cyclosarin exposure, an increase in reactivation of 
~33,000-fold relative to wt enzyme (where the wt rate was estimated to be 1 x 10-5 min-1, the 
lower limit of rate measurement).  Recall that no reactivation was observed with wt hCE1 in the 
presence of this OP.  Thus, efficient recovery of carboxylesterase activity following nerve agent 
exposure was achieved by introducing a pair of residues adjacent to the hCE1 active site.   
We next tested a series of single and double mutant controls containing Q residues at 
positions V146 and L363 to examine the effect of each mutant on reactivation rate (k3) with 
respect to sarin, cyclosarin, and soman hydrolysis (Figure 6.3.B, Table 6.1).  For sarin hydrolysis, 
introduction of a polar side chain (H or Q) in either position alone or in combination produced 
similar rates of reactivation, ranging from 3.2 × 10-4 to 26 × 10-4 min-1, up to a 11-fold increase 
relative to wt hCE1.  Following soman or cyclosarin inhibition, L363E appeared critical to 
increasing k3 from sub-detection limits in wt hCE1 to 4.0 × 10-4 and 19 × 10-4 min-1, up 8- and 
9,300-fold, respectively (Table 6.1).  For soman, polar residues at position 146 (H or Q) weakly 
stimulated reactivation; however, when V146H was combined with L363E, reactivation increased 
20-fold relative to wt hCE1 (Table 6.1).  
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However, the largest k3 enhancement was for cyclosarin and the V146H/L363E mutant.  
This designed enzyme exhibited an increased rate of enzyme-mediated cyclosarin 
dephosphonylation of >33,000-fold relative to the wt enzyme (Table 6.1). A second double-
mutant in which a Q at position 146 was combined with an E at position 363 was also found to 
exhibit robust enzyme reactivation following cyclosarin exposure, with an rate increase of 
>21,000-fold relative to wt hCE1 (Table 6.1).  Thus, a glutamic acid at position 363 appeared to 
function as a catalytic base to enhance cyclosarin reactivation; a glutamine in that position failed 
to stimulate enzyme activity in the presence of cyclosarin.  Taken together, these data 
demonstrate that targeted mutagenesis within hCE1 can significantly increase nerve agent 
processing by this serine hydrolase. 
6.3.3 Structural Mechanism for Enhanced Cyclosarin Hydrolysis 
 The crystal structure of hCE1 in covalent complex with cyclosarin was then used to 
generate an energy-minimized model of V146H/L363E hCE1. In the resultant model, the side 
chains of L363E and V146H were found to be 3.3 Å apart.  In addition, the orientation of L363E 
suggested that a water molecule could be positioned 3.2 Å from L363E and 3.2 Å from the 
phosphorous atom on the OP-enzyme adduct (Figure 6.4.A). Based on this model and the 
biochemical data presented above, we propose that L363E is positioned for water activation and 
is stabilized by H146 (Figure 6.4.B). Indeed, pH rate dependence studies showed that reactivation 
proceeded most effectively below pH 6.2, when V146H is likely to be positively charged (Figure 
6.4.C).   
6.3.4 Bimolecular Rates of Inhibition 
 To ensure that the enhanced rates of reactivation of V146H/L363E were not artifacts of 
altered substrate binding, we determined the bimolecular rates of inhibition (ki) of the mutant 
protein with racemic cyclosarin or stereoisomers of OP model compounds similar in structure to 
cyclosarin, and compared those rates to wt enzyme. V146H/L363E hCE1 exhibited a similar ki to 
wt hCE1, confirming that the ability of the mutant protein to bind cyclosarin and related OP 
 129 
compounds was not disrupted (Table 6.2, Table 6.3).  Indeed, as measured with stereoisomers of 
the model compounds, V146H/L363E exhibited an improved binding constant (Km) compared to 
wt hCE1 with either stereospecific compound 8. Therefore, the addition of an ion pair across the 
active site entrance was not detrimental to cyclosarin binding. 
6.4 Conclusions 
 OP nerve agents serve as hemisubstrates of the wild-type AChE, BChE, and hCE1 
enzymes because these chemicals fail to complete the typical two-step serine hydrolase 
mechanism. Rather, OP nerve agents produce relatively long-lived covalently phosphonylated 
active site serines 12,13. Histidine (H468 in wt hCE1; see Figure 6.2.B) activates the serine (S221 
in hCE1) for nucleophilic attack on the OP phosphonyl center.  The resultant pentahedral 
intermediate is stabilized by hCE1 backbone nitrogen atoms in the oxyanion hole (G142 and 
G143); the fluoride leaving group dissociates upon collapse of the transition state, resulting in a 
covalently modified enzyme 14. The resulting tetrahedral phosphonyl adduct adversely affects the 
ability of H468 to facilitate base mediated C-O bond cleavage 15, which leaves this residue in a 
state where it cannot activate the water molecule required for hydrolytic desphosphonylation 16.  
Thus, for serine hydrolases like AChE and hCE1 that are inhibited by OP hemisubstrates, the 
addition of a strong oxime is often required to complete the catalytic cycle and regenerate active 
enzyme. Current treatments following OP exposure include administration of strongly-
nucleophilic oximes to dephosphonylate AChE.  However, such compounds, such as 2-
pralidoxime obidoxime, do not offer broad-spectrum protection against all agents and must be 
administered quickly 17. 
 Based on previous crystal structures of hCE1 in covalent complexes with nerve agents 7,8, 
we hypothesized that introducing a general base catalyst would facilitate the activation of a 
properly located water molecule to hydrolyze an OP adduct. The V146H/L363E amino acid 
substitutions dramatically increased the spontaneous rates of enzyme reactivation following sarin, 
soman, and cyclosarin inhibition compared to native enzyme (Figure 6.3).  A panel of single and 
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double mutant controls indicated that V146H or L363Q facilitated increased sarin hydrolysis, 
while L363E acted as general base catalyst for cyclosarin and soman hydrolysis. Because V146H, 
L363Q, or their combination, resulted in similar rates of reactivation, these mutations may 
enhance dephosphonylation by interacting with the sarin O-isopropyl group, thereby affording 
deprotonation of the catalytic H468 for water activation and hydrolysis.  A G117H mutation in 
BChE resulted in increased rates of dephosphonylation through an analogous mechanism 16,18.   
In contrast, the L363E mutation positions an anionic carboxylate adjacent to the 
phosphonyl-enzyme intermediate to activate a water molecule for nucleophilic attack. Glutamic 
acid and aspartic acid residues act as general acid-base catalysts in several established enzyme 
mechanisms, including those of lysozyme and protein tyrosine phosphatases 19,20, and apparently 
support the same role in hCE1. The V146H addition synergistically increased base activity of 
L363E (Figure 6.4.A).   The pH profile for cyclosarin hydrolysis by V146H/L363E showed that 
the fastest rates of hCE1 reactivation was when H146 was likely to be in a charged state, below 
pH 6.2 and where a cationic H146 can stabilize the anionic base (Figure 6.4.C).  Based on these 
data, we postulate that E363 Oe1 is stabilized by H146 and Oe2 on E363 is available to 
deprotonate a water molecule to hydrolyze the covalent cyclohexyl phosphonyl group (Figure 
6.4.B).  This hypothesis is supported by the observation that the V146Q/L363E variant also 
exhibited a significant increase in cyclosarin hydrolysis (Table 6.1). 
 Previous attempts to introduce general base catalysts in OP-inhibited serine hydrolases 
have resulted in enzymes that also showed enhanced rates of reactivations against soman, sarin, 
and VX, but the ability of these mutant enzymes to bind the respective OPs was greatly 
diminished 10,16.  For example a G117H/E197Q BChE mutant enhanced the rate of soman 
hydrolysis up to 2,500-fold faster than wt BChE, but the soman bimolecular rate of inhibition for 
this mutant was decreased by a similar magnitude 10.  In contrast to the G117H/E197Q BChE 
mutant, V146H/L363E hCE1 exhibits a greater second-order rate of inhibition (ki) than the wt 
hCE1 enzyme (Table 6.2).  Further, the Km values for the cyclosarin model compounds reported 
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in Table II demonstrate that the affinity for V146H/L363E hCE1 is greater than the wt enzyme 
for these analogs. Taken together, these data show that V146H/L363E hCE1 retains greater than 
wt affinity for cyclosarin, and that the engineered hCE1 mutants enhance rates of reactivation via 
dephosphonylation rather than decreasing inhibition.  
 In conclusion, we have rationally designed a variant form of the liver detoxifying enzyme 
hCE1 that spontaneously dephosphonylates after inhibition by sarin, soman, and cyclosarin up to 
33,000-fold faster than wt enzyme. Wild type hCE1 has a catalytic efficiency (kcat/Km) 21 towards 
the standard esterase substrate para-nitrophenylbutyrate (pNPB) of 1.2 × 105 M-1s-1 22.  AChE, one 
of the most efficient enzymes known, exhibits a kcat/Km close to the diffusion control limit (108 M-
1s-1) for acetylcholine hydrolysis 23. Combining the nanomolar Km of V146H/L363E towards the 
PR cyclosarin-like compound along with rate of reactivation after inhibition by this compound, 
this double mutant shows a catalytic efficiency of 8.8 × 102 M-1s-1.  Thus, the redesigned hCE1 
compares favorably to other mammalian enzymes that have been rationally engineered to 
improve hemi-substrate metabolism (Table 6.4). This enzyme will likely require substantial 
increases in catalytic efficiency for OP compounds in order to provide in vivo protection, but 
nonetheless can serve as a lead candidate for further development of novel countermeasures for 
nerve agent or pesticide poisoning. 
 
 
 
 
 
 
 
 
 
 132 
 
 
Table 6.1 Rates of dephosphonylation for hCE1 mutants. N.R. is no reactivation with a detection 
limit < 1 × 10-5 min-1.  pH 7.4, 25oC, N=3, s.d.*k3 ~ 1 × 10-7 min-1, i.e. (1 × 10-5 min-1)*(1% 
activity)/100.   
 
 
 
 
 
 
 
 
 
 
hCE1 
Sarin Soman Cyclosarin 
k3 ( × 10-4 min-1) Fold Increase k3 (× 10-4 min-1) Fold Increase k3 (× 10-4 min-1) Fold Increase* 
WT 2.4 ± 0.5 - 0.5 ± 0.3 - < 0.01 - 
V146H 20 ± 4 8 2 ± 1 4 0.032 ± 0.006 16 
V146Q 3.2 ± 0.9 1 2 ± 1 4 0.34 ± 0.09 171 
L363E 4.6 ± 0.5 2 4 ± 1 8 19 ± 5 9,300 
L363Q 14 ± 1 6 < 0.01 - < 0.01 - 
V146Q/L363E 5.7 ± 0.7 2 2.6 ± 0.5 5 43 ± 7 21,500 
V146H/L363Q 26 ± 3 11 < 0.01 - < 0.01 - 
V146Q/L363Q 12 ± 1 5 < 0.01 - < 0.01 - 
V146H/L363E 12 ± 2 5 10 ± 1 20 67 ± 6 33,355 
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V146H/L363E ki ( × 103 M-1s-1) Km ( × 10-6 M) k3 ( × 10-4 min-1) 
Racemica 79 ± 2 N.D. 67 ± 6 
PRb 5.4 ± 0.4 0.095 ± 0.006 50 ± 10 
PSb 0.12 ± 0.02 5.2 ± 0.7 40 ± 10 
WT    
Racemica 11 ± 5 N.D. < 0.01c 
PRb 15 ± 1c 0.32 ± 0.01c < 0.01c 
PS b 0.0053 ± 0.0007c 1700 ± 200c < 0.01c 
Table 6.2 Bimolecular rates of inhibition, Michaelis-Menten constants, and rates of reactivation 
for wild-type and V146H/L363E hCE1 against racemic cyclosarin and stereoisomers of 
cyclosarin model compounds. N=3, s.d., N.D. is not determined, N.R. is no reactivation, pH 7.4, 
25°C aRacemic bona fide cyclosarin, bstereoisomers of cyclosarin model compounds, c(8). 
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hCE1 Model Compound 
ki (× 103 M-1s-1) Km (× 10-6 M) 
PR PS PR PS 
WTa 
Sarin 0.77 ± 0.05 4.1 ± 0.1 1.4 ± 0.2 0.37 ± 0.02 
Soman 2.5 ± 0.5 0.0015 ± 0.0007 0.22 ± 0.02 800 ± 200 
V146H/L363E 
Sarin 3.40 ± 0.07 4.7 ± 0.2 3.5 ± 0.8 0.9 ± 0.1 
Soman 10.8 ± 0.4 0.67 ± 0.06 0.101 ± 0.005 8 ± 2 
Table 6.3 Inhibition and Michaelis-Menten constants for wild-type and V146H/L363E hCE1 
against stereoisomers of sarin and soman model compounds. (N=3, s.d.) a(7). 
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Enzyme Engineered Activity Mutation(s) Catalytic Efficiency (M-1s-1) 
Butyrylcholinesterase Sarin hydrolysisa G117H 0.79 
Glutathione Transferase A1-1 Thioester hydrolysisb A216H 2.60 
4-Oxalocrotonate Tautomerase Oxaloacetate decarboxylasec P1A 114 
Phospho(serine/threonine/tyrosine) 
Binding Protein 
Phosphatase 
activityc G120C 490 
Human Carboxylesterase 1 Cyclosarin analog hydrolysis V146H/L363E 877 
Cyclophilin Protease activityc 
A91S/F104H 
/N106D 1675 
Table 6.4 Catalytic efficiencies (kcat/Km) of engineered enzymes towards hemisubstrates. a(16) 
b(32) c(32) 
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Figure 6.1 Organophosphate (OP) Inhibition of Human Carboxylesterase 1 (hCE1) 
 
A. Three G-type OP nerve agents and OP model compound (R represents respective O-alkoxy 
groups).  Wild-type hCE1 preferentially binds the stereoisomers shown 7.   
B. Schematic mechanism of OP hydrolysis by hCE1.  X represents the leaving group and * 
denotes a non-reactive state. 
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Figure 6.2 Human Carboxylesterase 1 Active Site Structure.  
 
Active site of human carboxylesterase 1 covalently inhibited via S221 with cyclosarin (magenta) 
8.  The other catalytic residues, in addition to S221, are H468 and E354 (yellow), and are 
surrounded by hydrophobic residues (grey surface) including V146 and L363 (light blue), as well 
as the oxyanion hole (white).	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Figure 3.  Reactivation of hCE1 following nerve agent exposure.   
 
A. Spontaneous reactivation of V146H/L363E hCE1 following inhibition by racemic sarin 
(blue), soman (green), or cyclosarin (red).  Wild type hCE1 (grey) only reactivates following 
sarin inhibition 7. n=6, s.d.   
B. Rates of dephosphonylation for hCE1 variants in the presence of sarin (blue), soman 
(green) and cyclosarin (red). n=3, s.d. 
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Figure 4.  Mechanism of reactivation by V146H/L363E hCE1 after cyclosarin binding.  
 
A. Model of V146H/L363E (cyan) hCE1 with PR cyclosarin (magenta) including a water 
molecule (red) between E363 and the central phosphorus.    
B. Proposed mechanism for enhanced reactivation following cyclosarin inhibition.   
C. pH dependence of V146H/L363E (black) and L363E (grey) hCE1 dephosphonylation 
following cyclosarin inhibition.  
A 
C 
B 
 140 
6.5 References 
1. Dixon M, Webb EC (1979) In: Boyer PD, editor. Enzymes. 3rd ed. New York: Academic 
Press. pp. 333. 
 
2. Newmark J (2007) Nerve agents. Neurologist 13: 20-32. 
 
3. Ohbu S, Yamashina A (1997) Sarin poisoning on Tokyo subway. Southern Medical Journal 90: 
587-693. 
 
4. Gunnell D, Eddleston M, Phillips MR, Konradsen F (2007) The global distribution of fatal 
pesticide self-poisoning: systematic review. BMC Public Health 7: 357. 
 
5. Jett DA Finding new cures for neurological disorders: a possible fringe benefit of biodefense 
research? Sci Transl Med 2: 23ps12. 
 
6. Redinbo MR, Potter PM (2005) Mammalian carboxylesterases: from drug targets to protein 
therapeutics. Drug Discov Today 10: 313-325. 
 
7. Fleming CD, Edwards CC, Kirby SD, Maxwell DM, Potter PM, et al. (2007) Crystal structures 
of human carboxylesterase 1 in covalent complexes with the chemical warfare agents soman and 
tabun. Biochemistry 46: 5063-5071. 
 
8. Hemmert AC, Otto TC, Wierdl M, Edwards CC, Fleming CD, et al. (2010) Human 
carboxylesterase 1 stereoselectively binds the nerve agent cyclosarin and spontaneously 
hydrolyzes the nerve agent sarin. Mol Pharmacol 77: 508-516. 
 
9. Marcel V, Estrada-Mondaca S, Magne F, Stojan J, Klaebe A, et al. (2000) Exploration of the 
Drosophila acetylcholinesterase substrate activation site using a reversible inhibitor (Triton X-
100) and mutated enzymes. J Biol Chem 275: 11603-11609. 
 
10. Millard CB, Lockridge O, Broomfield CA (1998) Organophosphorus acid anhydride 
hydrolase activity in human butyrylcholinesterase: synergy results in a somanase. Biochemistry 
37: 237-247. 
 
11. Wierdl M, Tsurkan L, Hyatt JL, Edwards CC, Hatfield MJ, et al. (2008) An improved human 
carboxylesterase for enzyme/prodrug therapy with CPT-11. Cancer Gene Ther 15: 183-192. 
 
12. Casida JE, Quistad GB (2005) Serine hydrolase targets of organophosphorus toxicants. Chem 
Biol Interact 157-158: 277-283. 
 
13. Gilley C, MacDonald M, Nachon F, Schopfer LM, Zhang J, et al. (2009) Nerve agent 
analogues that produce authentic soman, sarin, tabun, and cyclohexyl methylphosphonate-
modified human butyrylcholinesterase. Chem Res Toxicol 22: 1680-1688. 
 
14. Lenz DE, Broomfield CA, Yeung D, Masson P, Maxwell DM, et al. (2008) Nerve Agent 
Bioscavengers: Progress in Development of a New Mode of Protection against 
Organophosphorus Exposure. In: Romano Jr. JA, Lukey BJ, Salem H, editors. Chemical Warfare 
Agents: Chemistry, Pharmacology, Toxicology, and Therapeutics. 2nd ed. Boca Raton, FL: CRC 
Press. pp. 175-202. 
 141 
15. Qian N, Kovach IM (1993) Key active site residues in the inhibition of acetylcholinesterases 
by soman. FEBS Lett 336: 263-266. 
 
16. Millard CB, Lockridge O, Broomfield CA (1995) Design and expression of 
organophosphorus acid anhydride hydrolase activity in human butyrylcholinesterase. 
Biochemistry 34: 15925-15933. 
 
17. Kuca K, Jun D, Bajgar J (2007) Currently used cholinesterase reactivators against nerve agent 
intoxication: comparison of their effectivity in vitro. Drug Chem Toxicol 30: 31-40. 
 
18. Lockridge O, Blong RM, Masson P, Froment MT, Millard CB, et al. (1997) A single amino 
acid substitution, Gly117His, confers phosphotriesterase (organophosphorus acid anhydride 
hydrolase) activity on human butyrylcholinesterase. Biochemistry 36: 786-795. 
 
19. Vocadlo DJ, Davies GJ, Laine R, Withers SG (2001) Catalysis by hen egg-white lysozyme 
proceeds via a covalent intermediate. Nature 412: 835-838. 
 
20. Denu JM, Dixon JE (1998) Protein tyrosine phosphatases: mechanisms of catalysis and 
regulation. Curr Opin Chem Biol 2: 633-641. 
 
21. Wolfenden R (2006) Degrees of difficulty of water-consuming reactions in the absence of 
enzymes. Chem Rev 106: 3379-3396. 
 
22. Wadkins RM, Morton CL, Weeks JK, Oliver L, Wierdl M, et al. (2001) Structural constraints 
affect the metabolism of 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin 
(CPT-11) by carboxylesterases. Mol Pharmacol 60: 355-362. 
 
23. Elcock AH, Gabdoulline RR, Wade RC, McCammon JA (1999) Computer simulation of 
protein-protein association kinetics: acetylcholinesterase-fasciculin. J Mol Biol 291: 149-162. 
 
24. Morton CL, Potter PM (2000) Comparison of Escherichia coli, Saccharomyces cerevisiae, 
Pichia pastoris, Spodoptera frugiperda, and COS7 cells for recombinant gene expression. 
Application to a rabbit liver carboxylesterase. Mol Biotechnol 16: 193-202. 
 
25. Hovanec JW, Broomfield CA, Steinberg GM, Lanks KW, Lieske CN (1977) Spontaneous 
reactivation of acetylcholinesterase following organophosphate inhibition. I. An analysis of 
anomalous reactivation kinetics. Biochim Biophys Acta 483: 312-319. 
 
26. Aurbek N, Thiermann H, Szinicz L, Eyer P, Worek F (2006) Analysis of inhibition, 
reactivation and aging kinetics of highly toxic organophosphorus compounds with human and pig 
acetylcholinesterase. Toxicology 224: 91-99. 
 
27. Chen VB, Arendall WB, 3rd, Headd JJ, Keedy DA, Immormino RM, et al. (2009) 
MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr D 
Biol Crystallogr 66: 12-21. 
 
28. Dunbrack RL, Jr., Cohen FE (1997) Bayesian statistical analysis of protein side-chain rotamer 
preferences. Protein Sci 6: 1661-1681. 
 
29. Mayo S, Olafson B, Goddard W (1990) DREIDING: A Generic Force Field for Molecular 
Simulations. J Phys Chem 94: 8897-8909. 
 142 
30. Shortle D (2003) Propensities, probabilities, and the Boltzmann hypothesis. Protein Sci 12: 
1298-1302. 
 
 
